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ABSTRACT
For over a decade, DNA microarrays have dominated genome-wide gene expression
studies, revealing widespread effects of drug exposure on neuronal gene expression. More
targeted single gene approaches have added invaluable insights into their behavioral,
biochemical, and molecular effects. The more powerful next-generation sequencing
technology may soon supplant microarrays for the analysis of complex transcriptomes. RNASeq is unparalleled in its ability to identify and quantify low-abundance transcripts without
prior sequence knowledge, facilitating detection and investigation of known and novel
alternative splicing events, imprinting, and RNA editing, among others. We first used RNA-Seq
technology to catalog microRNA (miRNA) expression in total tissue and at postsynaptic
densities (PSDs) from control and cocaine-treated mice. Neurons modulate gene expression
with subcellular precision through excitation-coupled local protein synthesis, a process that
may be regulated in part through the involvement of miRNAs. We identified cocaineresponsive miRNAs, synaptically-enriched and depleted miRNA families, and confirmed
cocaine-induced changes in protein expression for several predicted target genes. The miR-8
family was found to be highly enriched and cocaine-regulated at the PSD, where its members
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may modulate expression of cell adhesion molecules. We then used next-generation
sequencing of mRNAs purified from the same brain regions to gain a more complete picture of
the molecular response to chronic cocaine exposure and withdrawal. Bioinformatic analysis
revealed paradigm-specific regulation of multiple components of a limited number of
signaling pathways. We identified signaling pathways that utilize distinctly different sets of
receptors and signaling molecules under control conditions, after chronic exposure to cocaine,
and during withdrawal. The Rho-GEFs expressed in the nucleus accumbens and localized to
the postsynaptic density were reviewed because they are strategically positioned to effect
rapid alterations in dendritic spine structure. Structural changes mediated by synaptic Rho
guanine nucleotide exchange factors (GEFs) control actin cytoskeletal rearrangements and
contribute to the long-lasting effects of cocaine. This review is then followed by a brief look at
several ongoing and completed collaborative bioinformatics projects. Future studies will
employ integrative approaches that combine mRNA, miRNA, and protein expression profiling
with focused single gene studies and innovative behavioral paradigms and will facilitate
development of integrated approaches to treat addiction.
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CHAPTER 1
Global approaches in the analysis of drug-induced gene
expression

System-wide analysis of gene expression
Microarray versus RNA-Seq: The advantages of sequencing
DNA microarrays have dominated genome-wide studies of gene expression for more
than a decade. However, the use of next-generation sequencing methods for the analysis of
complex transcriptomes may soon supersede the use of microarrays1. Microarrays have been
instrumental in the interrogation and profiling of DNA-protein interactions, identification of
single-nucleotide polymorphisms, and comparative analyses of mRNA expression2. Any
approach that attempts to deliver a global snapshot of gene expression has limitations,
however microarrays are limited in a number of ways that next-generation sequencing is not.
For example, microarrays rely on base complementarity between the probe and the mRNA
and therefore researchers must consider artifacts of cross-hybridization when dealing with
highly homologous genes or isoforms3. Microarrays contain a pre-defined set of
oligonucleotide probes designed using existing gene annotations for organisms with known
genome sequences1, whereas sequencing facilitates the identification and absolute
quantification of low-abundance transcripts without prior knowledge of the sequence3-6. The
sequencing approach, unlike microarray, has low background signal because of the
unambiguous nature of sequence mapping and has increased sensitivity for low-abundance
transcripts1,6. Additionally, sequencing enables the detection and investigation of alternative
splicing (both known and novel)4,5,7, imprinting and allele specific expression8, sequence
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variation6, and RNA editing9. And finally, microarrays provide far less data than current nextgeneration sequencing technologies, which can produce gigabases (109 nucleotides) of
sequence from a single experiment, enabling detection of very minor transcripts1.

Explosion of the sequencing field
In 1975, Sanger and Coulson published their breakthrough paper on rapid
determination of sequences in bacteriophage φX174 DNA using synthetic oligonucleotide
primers and Escherichia coli DNA polymerase I10. This was followed in 1977 by two landmark
Sanger et al. publications detailing the use of radioactively labeled, chain-terminating 2’,3’dideoxynucleotide phosphates (ddNTPs) for rapid DNA sequencing with DNA polymerase11,
revolutionizing modern molecular biology and characterizing the full genome of φX17412. Also
in 1977, Maxam and Gilbert presented an innovative method of sequencing by partial
cleavage of terminally labeled DNA molecules at each of the four bases followed by gel
electrophoresis13.
Since its introduction in the mid-1970s, rapid sequencing research has exploded, as
evidenced by the exponential increase in publications in the past few years (Fig. 1.1). The first
truly high-throughput sequencing device was introduced by Lynx Therapeutics in the 1990s.
Massively parallel signature sequencing (MPSS) employed microbead arrays for the analysis of
mRNA transcript levels. This approach involved in vitro cloning of cDNA templates on a
monolayer of slide-fixed microscopic beads followed by ligation of tagged adaptor sequences,
and produced ‘signature’ sequences ranging from 16 to 20 nucleotides in length14,15.
In 2005, two new methods of next-generation sequencing were introduced: (1)
pyrosequencing, or ‘sequencing-by-synthesis’, which detects pyrophosphate release on
nucleotide incorporation, was developed by 454 Life Sciences16, and (2) multiplex
‘sequencing-by-ligation’ of mate-paired polymerase colonies (‘polonies’)17. Also in 2005, Lynx
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Figure 1.1 PubMed references for high-throughput sequencing by year.
The number of publications in Entrez PubMed (http://www.ncbi.nlm.nih.gov/pubmed) by indicated
year for the search term ‘“RNA-seq” or “next-generation sequencing” or “massively parallel sequencing”
or “high-throughput sequencing” or “deep sequencing”’. Hashed bar depicts the 2011 predicted total.
Symbols: ‡, publication total obtained May 11, 2011; §, projected total for December 31, 2011.
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Therapeutics merged with another sequencing company, Solexa. In 2006, Solexa introduced
the Genome Analyzer, which, using sequencing by synthesis with fluorescent reversible
terminator technology, provided up to 1 gigabase (Gb) of sequence in a single sequencing
run. In 2007, Illumina aquired Solexa, and as of 2011, Illumina sequencers generate up to 600
Gb of sequence per run18. An additional technology, SOLiD (Sequencing by Oligonucleotide
Ligation and Detection) from Applied Biosystems, gained renown in 2008 with the sequencing
of the stem cell transcriptome4. Next-next-generation (3rd generation) sequencing, in which
single molecules are sequenced without prior amplification, are considered the future of the
sequencing field19.

Limitations in current RNA-Seq methods
High-throughput sequencing is an extremely powerful tool for biological analysis, but
it would be shortsighted not to touch on some of its limitations. The density of sequence reads
varies along the length of a transcript, indicating the existence of sequence bias at some point
during the library preparation or sequencing process (Fig. 1.2)20,21. There are data showing an
underrepresentation of AT-rich and GC-rich regions in Illumina RNA-Seq data, which is likely
attributable to sequence bias during the reverse transcription and amplification steps of
library preparation3,22,23. Strand-specific sequencing, in which the sequencing adapters are
ligated to the RNA fragment prior to amplification, may show a more even distribution of
aligning reads along the length of the gene; this method, however, requires additional
manipulation of highly labile RNA prior to its conversion to more stable cDNA19. Other
difficulties of traditional RNA-Seq include issues of quantifying very low abundance
transcripts, problems with profiling repetitive regions of the genome, and trouble in
quantifying small RNAs and RNA with a short half-life19. Next-next-generation sequencing
provides an alternative that avoids many of the weaknesses of currently used methods.

5

Figure 1.2 Exon coverage profile with RNA-Seq using different sequencing platforms.
Expression profile of poly(A)+ mRNAs from NAc tissue lysates and striatal PSDs. Data from NAc samples
were obtained from 37-cycles of sequencing on the Genome Analyzer IIx. Data from PSD samples were
generated using the HiSeq 2000 platform and sequencing was carried out for 100-cycles. Numbers to
the left of each track indicate maximal read number for that sample.
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Challenges accompany the rapidly improving technology and accumulation of
datasets containing vast amounts of information, however. Many biologists struggle to make
scientific sense of the data at hand, while many computer scientists are not equipped with the
biology training to tackle the relevant questions on their own. A growing number of tools are
available to assist in the analysis of high-throughput datasets, including packages for
sequence alignment24, de novo genome and transcriptome assembly25, analysis of alternative
splicing26, functional category assessment, and identification of signaling pathway
enrichment27-30. The field is in its infancy, and, at present, few ‘user friendly’ and fully
customizable packages exist for the comprehensive analysis of sequencing data. It will be
exciting to follow new and improving developments as they become available.

Applying high-throughput techniques to the analysis of gene expression in
the brain
mRNA studies
In one of the first global analyses of mRNA expression in the mammalian brain,
Eberwine et al. amplified transcripts from single dissociated rat hippocampal neurons31.
Through this analysis they found differing expression profiles in morphologically
indistinguishable neurons, highlighting the extraordinary complexity that dictates neuronal
gene regulation31.
In 2003, Ule and colleagues presented a novel method to analyze direct interactions
between the RNA binding protein and splicing cofactor, Nova, and its target mRNAs32. The
technique, cross-linking and immunoprecipitation (CLIP), involves direct ultraviolet irradiation
of brain tissue, causing the formation of covalent bonds between directly juxtaposed proteins
and RNAs. They then used coimmunoprecipitation (co-IP) of Nova, followed by partial RNA
digestion and proteinase K digestion to obtain RNA sequences of 60-100 nt. They sequenced
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340 Nova CLIP tags, identifying many novel Nova alternative splicing targets32.
Expanding on the role of Nova proteins in the control of neuronal alternative splicing,
Ule et al. used a specially-designed Affymetrix splicing array to assess alternative splicing in
the brains of two knockout mice, Nova1-/- and Nova 2-/-, identifying nearly 50 differentially
spliced alternative exons33. Shortly thereafter, Ule et al. used bioinformatic techniques to
characterize an RNA map of Nova-dependent alternative splicing in the brain, identifying
splicing enhancer and silencer motifs in and around alternatively spliced exons34.
With the advent of next-generation sequencing techniques, the same group
developed HITS-CLIP, high-throughput sequencing of RNA isolated by crosslinking
immunoprecipitation35. This technique used the previously described32 CLIP method paired
with RNA-Seq of isolated mRNAs. They performed a genome-wide characterization of NovaRNA interactions, identifying an added role for Nova in the regulation of polyadenylation in
the mammalian brain35. These examples, and others not included, underscore the utility and
power of genome-wide approaches in the study of gene expression in the mammalian brain.

microRNA studies
microRNAs (miRNAs) are a class of endogenous 21-25 nucleotide small RNAs that
modulate gene expression through binding complementary sequences in the 3’-untranslated
regions (3’-UTRs) of target mRNAs36. Hundreds of miRNAs are expressed in the mature
mammalian brain37-40, where they are involved in the control of synapse development and
neuronal plasticity41. In the biogenesis of mature miRNAs, long primary miRNA (pri-miRNA)
transcripts are successively cleaved into shorter preliminary miRNA (pre-miRNA) hairpins,
exported from the nucleus, and cleaved to make ~22 nt duplex RNAs prior to loading into
RNA-induced silencing complexes (RISCs)36. Each fully assembled RISC contains an Argonaute
protein (AGO1-4 in human and mouse), and a single mature miRNA42. The RISC interacts with
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target mRNAs via complementary base pairing interactions specified by the miRNA sequence,
and either represses translation or induces mRNA degradation. AGO2 is the only catalytically
active AGO family member in humans and mice; it has endonuclease (‘slicer’) activity and the
ability to cleave target mRNAs36.
Neurons can modulate gene expression with subcellular precision; polyribosomes and
mRNAs are found at the base of dendritic spines and are involved in localized protein
synthesis43,44. Two recent publications present evidence that individual synapses may act
independently in the local control of excitation-coupled protein translation41,45. A subset of
miRNAs copurify with polyribosomes isolated from E18 rat cortices, suggesting a role for
miRNAs in fine-tuning localized translation of mRNAs in dendrites46. Localization of the miRNA
processing enzyme DICER and the critical RISC component AGO2 in mouse cortical and
hippocampal slices by electron microscopy lent credence to this hypothesis47. Further studies
identified the RISC component and RNA helicase Armitage (also known as MOV10) at the
synapse and established a role for RNA-induced silencing in the control of synaptic gene
expression, learning, and memory48,49. The demonstration that miR-134 was a synaptodendritically localized miRNA with a role in activity-dependent regulation of hippocampal
dendritic spine size through its effects on the kinase LIMK150 was followed by studies
demonstrating roles for miR-132 and miR-138 in dendritic remodeling and synaptogenesis51,52.
Applying the HITS-CLIP technique35 of protein crosslinking and high-throughput
sequencing, Chi et al. simultaneously generated two distinct RNA-Seq databases by
immunoprecipitating AGO2 from mouse brain53. One database provided a genome-wide map
of AGO2-mRNA binding sites, and the other detailed the association of AGO2 with specific
miRNAs. Through bioinformatic means, they were able to characterize a combined global
AGO2-miRNA-mRNA map, providing further evidence for the importance of miRNA-mediated
control of gene expression in the brain53.
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miRNAs are implicated in the pathophysiology of a variety of neuropsychiatric
disorders and mental retardation syndromes, including Alzheimer’s disease, Parkinson’s
disease54, Huntington’s disease55, schizophrenia56,57, bipolar disorder58, Fragile X mental
retardation59, and Rett syndrome60,61. Studies suggest that miRNAs play an important role in
the local control of dendritic morphology through fine-tuning translation of synapticallylocalized mRNAs41. miRNAs likely participate in long-lasting forms of synaptic plasticity
through the modulation of regulatory pathways that involve controlled dendritic mRNA
trafficking, excitation-coupled modulation of synaptic mRNA translation, alterations to the
actin cytoskeleton, neurotransmitter metabolism and peptide hormone processing62.

Proteomic studies
Characterization of the complete complement of proteins expressed in the brain has
been ongoing for years. Current proteomic approaches lack the same level of sensitivity seen
in current high-throughput sequencing techniques, limited by our inability to amplify proteins
as we amplify nucleic acids63.
Expression neuroproteomic studies focus on quantitative and qualitative profiling of
the neural proteome using gel electrophoresis, 2-dimensional difference in gel electrophoresis
(2D-DIGE), and liquid chromatography-tandem mass spectrometry (LC-MS/MS)64. Functional
neuroproteomic studies tackle the characterization of regulatory networks, signaling
pathways, subcellular localization, and complex formation64. The Human Brain Proteome
Project is an organization that oversees large-scale integration of brain proteome studies65.
Over 1,000 proteins have been identified in the mammalian postsynaptic proteome66.
The postsynaptic proteins are organized into signaling complexes and networks, including the
NMDA receptor complex67, dozens of actin cytoskeletal and scaffolding proteins68, and
approximately 60 kinases64.
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One aspect of proteomics addresses post-translational modifications to proteins,
including phosphorylation, glycosylation, nitrosylation, carbonylation, palmitoylation, etc.
Phosphoproteomic studies have identified more than 1,500 phosphorylation sites in isolated
postsynaptic densities (PSDs) from different brain regions64. Studies have revealed widespread
activity-dependent phosphorylation of specific target proteins in the PSD in response to
neurotransmitter stimulation69. For example, a recent study of the postsynaptically-localized
Rho GDP/ GTP exchange factor (GEF) Kalirin-7 found 39 different phosphorylation sites using
LC-MS/MS70.

Cocaine abuse
History of cocaine
In 1977, the National Institute on Drug Abuse (NIDA) released its first report on
recreational cocaine use in the United States71. The report detailed the present state of
cocaine-related research, including the history of cocaine use and abuse, the chemical
structure and metabolism of the drug, behavioral studies, and a survey of the human impact
of cocaine use. The coca plant, Erythroxylon coca, is indigenous to Western South America,
where for millennia people have chewed the coca leaf for its stimulant and perceived
medicinal qualities. Cocaine extract was first purified in 1880, and by the turn of the 20th
Century it was widely used in a variety of commercially available products, such as soft drinks,
wines, and many over-the-counter medicines. The Harrison Narcotics Act of 1914 ushered in a
new era of Federal oversight, restricting the availability of cocaine and coca extracts, and
imposing significant fines for non-medical use71.
By the late 1960s, researchers had developed many of the animal models of substance
abuse still in use today, including the paradigm of self-administration. The molecular and
biochemical underpinnings of substance abuse and addiction were nearly entirely unknown,
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and the impact on the general population of the United States was quite minor, accounting
for just 111 documented deaths from 1971 to 197671. In the subsequent 35 years, our
knowledge of cocaine and its biological activity has increased immensely, as has the burden
on the general population of cocaine-related morbidity and mortality.

Societal impact of substance abuse and addiction
Repeated cocaine use may lead to addiction and a number of other serious and
adverse health consequences, and cocaine accounts for nearly one third of all drug-related
emergency room visits72. In 2007, there were 1.6 million cocaine users in the United States who
met the Diagnostic and Statistical Manual of Mental Disorders criteria for dependence or
abuse of cocaine in the past year73,74. Approximately 90% of addicted individuals eventually
resume drug taking, many after prolonged periods of abstinence75. Our understanding of the
molecular underpinnings of cocaine abuse and addiction is far from complete, and there are
currently no FDA-approved medications to treat cocaine addiction76. Studies such as those
detailed herein aim to elucidate the genetic changes underlying the response of the brain to
cocaine and may ultimately help identify new targets for treating cocaine addiction.
Drug abuse research primarily aims to uncover the molecular and cell biological
mechanisms causing addiction in humans. Addiction is currently a clinical diagnosis, defined
as the compulsive need for and use of a habit-forming substance despite its harmful
consequences73. Until recently, evidence in support of an appropriate animal model of
addiction was limited. In 2004, Piazza and colleagues put forth convincing evidence in support
of addiction-like behavior in the rat77. The authors described rats trained to self-administer
cocaine that, when cocaine was paired with an aversive foot shock, persisted seeking drug77;
this behavior is present in a minority of rats and human drug addicts and is a strong predictor
of relapse potential after withdrawal. The endogenous reward system of the brain, on which
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drugs of abuse act, is similar in many different species. For decades, the use of a variety of
animal models, to study the behavioral and neurochemical response to drug exposure, has
shed light on the neuroadaptations occurring inside the brains of human drug abusers.

The reward circuitry of the brain
Drugs of abuse induce persistent biochemical and morphological changes in a
number of regions throughout the brain via distinct acute mechanisms of action. Abundant
evidence, from both animals and humans, identifies the limbic system as the convergence
point for all drugs of abuse78-83. The limbic regions of the brain control emotions, motivations,
and behavior. The mesocorticolimbic dopamine pathway, which involves a subset of all limbic
structures, is activated by normal physiologic rewards such as food, drink, social interaction,
and sex84-86. The mesocorticolimbic system includes dopaminergic projections from the ventral
tegmental area (VTA) to the nucleus accumbens (NAc) and prefrontal cortex (PFC) as well as
glutamatergic projections from the PFC to the NAc (Fig. 1.3)87. Although drugs of abuse
originate from a diverse array of chemical classes and have a variety of different primary
targets, their effects all ultimately converge on the mesocorticolimbic dopamine neurons of
the VTA88. Other neurotransmitters, including γ-aminobutyric acid (GABA), opioid peptides,
serotonin, acetylcholine, and endogenous cannabinoids, are also involved in the signaling of
addiction89-91. The convergence of these myriad signaling systems has led many to
hypothesize that the NAc is the key integration point in the rewarding effects seen with drugs
of abuse83,92-95.
The neuronal circuitry of drug craving is complex and incompletely understood;
however, data from animal studies and functional imaging of the brains of human addicts
have uncovered a number of important details (Fig. 1.3). A variety of drug-related cues may
spur a reformed addict to resume drug-seeking behavior; these cues include stress, exposure
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Figure 1.3 The reward circuitry of the mesocorticolimbic dopamine system.
The VTA is comprised of both GABAergic and dopaminergic neurons that project to the NAc, dorsal
striatum, and PFC. The neurons of the NAc receive glutamatergic input from the PFC, amygdala, and
hippocampus and send GABAergic efferents to the VP, back to the VTA, and to motor regions.
Glutamatergc afferents carry motivational signals to the NAc. The NAc signals function to direct the
execution of goal-oriented behavior, including sending signals to motor control regions (not shown).
The mixed cholinergic, glutamateric, and GABAergic efferents from the LTD and PPT modulate signaling
in the VTA. Coloring of structures reflects neurotransmitter type, with multi-colored structures (eg. VTA)
using more than one neurotransmitter to signal.
Abbreviations: LDT/PPT, laterodorsal tegmental nucleus/pedunculopontine tegmental nucleus; NAc,
nucleus accumbens; PFC, prefrontal cortex; VP, ventral pallidum; VTA, ventral tegmental area.
* Figure adapted from Kauer and Malenka, Nat. Rev. Neurosci., (2007)87 and Wolf, M.E. in Basic
Neurochemistry: Molecular, Cellular, and Medical Aspects, (2006)88.
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to a small dose of drug, and/or exposure to drug paraphernalia or the drug-related
environment88,90. These cues activate glutamatergic neurons from the PFC that synapse on the
medium spiny neurons of the NAc (shown in blue in Fig. 1.3). Aspects of the normal stress
response in the brain, mediated by the circuitry of the hypothalamic-pituitary-axis, exhibit
profoundly disrupted regulation in the brains of chronic drug users88. The PFC controls the
cognitive and executive function aspects of drug-taking behavior while the other brain
regions involved in the mesocorticolimbic circuitry are thought to control various components
of learning, memory, and motivational significance that modulate drug-seeking behavior90. It
is likely a combination of cognitive dysfunction with increased motivation to take a drug,
enhanced conditioned emotional responses, and decreased inhibitory control/judgment that
dictate compulsive drug-seeking behavior88.
Chronic cocaine exposure elicits morphological changes in multiple areas of the
mesolimbic dopaminergic pathway, including the NAc88. For example, increased dendritic
spine size and density are observed in the MSNs of mice following both experimenteradministered68,96-98 and self-administered cocaine99. The biology underlying the behavioral and
motivational responses experienced by drug abusers are generally described by two
phenomena: sensitization and synaptic plasticity. Sensitization is the progressive and
persistent amplification of behavioral and motivational responses to a fixed dose of drug93,95. It
persists for weeks, months, and years after cessation of drug taking and is thought to play an
important role in the risk of a reformed addict for relapse to drug taking behavior100-102.
Synaptic plasticity is the phenomenon whereby the strength of the connection between two
neurons changes strength. This change could be due to alterations in presynaptic
neurotransmitter release, postsynaptic ion channel composition or conductivity, the
morphology of the synapse, and/or second messenger signaling, all of which may be
controlled by changes in gene transcription86. Synaptic plasticity is strongly implicated in all
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types of learning, and current research suggests that drugs of abuse hijack normal synaptic
plasticity mechanisms in the mesolimbic system with higher potency than natural rewards,
leading to the development of sensitization84; addicts effectively “learn” to like the drug.

Overview of signaling pathways
Medium spiny neurons (MSNs) are the inhibitory GABAergic neurons that comprise 9095% of the neurons in the nucleus accumbens87. Dendritic spines of medium spiny neurons
receive dopaminergic inputs on their spine necks and glutamatergic inputs on their spine
heads, positioning them well to integrate the complex signaling of the mesolimbic
system95,103. When cocaine is present at the synapse, it blocks presynaptic dopamine re-uptake
by the dopamine transporter (DAT), enhancing postsynaptic dopamine signaling by
prolonging the time dopamine is present in the synapse and can bind postsynaptically.
Dopamine signaling is central to the mechanism by which rewarding stimuli, both natural and
synthetic, modulate behaviors and promote learning of rewarding behaviors88. Drugs of abuse
activate dopamine neurons of the VTA through direct or indirect mechanisms, eliciting
increased dopamine release and causing widespread changes – in gene expression,
neurotransmitter release, signal transduction, neuronal excitability, and morphology – in
dopamine-targeted neurons83,88.
A variety of drugs of abuse induce a sensitized state, akin to the increased synaptic
efficacy of long-term potentiation (LTP), in the dopamine neurons of the VTA; dopamine
transmission in response to the drug or drug-related cues is greatly increased over the drugnaïve baseline 83. Increased responsiveness of ionotropic glutamate receptors of the α-amino3-hydroxy- 5-methyl-4-isoxazole propionic acid (AMPA) subtype govern this sensitization and
may reflect altered AMPA receptor trafficking or subunit composition87. Furthermore, altered
glutamatergic signaling has been implicated in behavioral responses to drugs of abuse83.
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Decreased GABA transmission in the VTA, mediated by exposure to opiates, ethanol,
and cannabinoids, disinhibits efferent dopamine neurons, increasing dopamine release and
signaling in the NAc, PFC, and other target areas (Figs. 1.3)88. Additionally, opiate drugs
activate signaling in the NAc independent of their effects on VTA dopamine transmission
through the binding of opiate peptides to presynaptic κ-opioid receptors and postsynaptic µopioid receptors in the NAc88,90.
Chronic exposure to cocaine markedly increases expression of µ- and κ-opioid
receptors in the NAc. Activation of µ-type receptors on dopamine neurons of the VTA
stimulates synaptic dopamine release while presynaptic κ-type activation in the NAc is
homeostatic, diminishing dopamine release104,105. In the NAc, µ-opioid receptor expression is
primarily postsynaptic and κ-opioid receptors are both pre- and postsynaptic, although the
postsynaptic subset predominates106. Cocaine exposure induces striatal expression of the
opiate peptide dynorphin (and its precursors), which primarily binds the κ-opioid receptor,
and treatment with κ-opioid agonists significantly reduces the behavioral effects of cocaine107.
Drugs of abuse directly and indirectly activate of Gαs and Gαi/o G-protein coupled
receptors (GPCRs). Gαs GPCRs, such as the D1-like dopamine receptors, produce the second
messenger cyclic adenosine monophosphate (cAMP) through activation of adenylyl cyclase.
The resultant increase in intracellular cAMP levels increases the activity of the Protein Kinase A
(PKA) family of Ser/Thr kinases. Activated PKA translocates to the nucleus where it
phosphorylates the transcription factor CREB (cAMP response element binding), inducing
transcription of a variety of target genes. Alternatively, Gαi/o GPCRs, such as the D2-like
dopamine receptors, inhibit adenylyl cyclase, decreasing the amount of cAMP and decreasing
downstream PKA signaling events108. Both D1 and D2 receptors act through additional
signaling mechanisms to exert their full effects88.
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Importantly, dopamine signaling in mesolimbic MSNs performs a neuromodulatory
role. The D1 receptor-PKA pathway influences neuronal excitability through PKA-mediated
phosphorylation of voltage- and ligand-gated ion channels. Examples of regulated channels
include glutamate receptors of both the AMPA and NMDA type, Na+ channels, and Ca2+
channels88. Increased intracellular Ca2+ levels mainly activate calcium/calmodulin-dependent
protein kinases (CaM-kinases), ultimately turning on CREB and affecting gene expression108.
Repeated stimulation produces persistent changes in gene expression that cause changes in
pre- and postsynaptic neuronal morphology and alter the underlying neuronal circuitry88.
Drugs of abuse exert their influence on the reward and motivation pathways in the brain by
hijacking the normal signaling of activity-dependent plasticity and LTP.

Global analyses of cocaine-mediated gene expression
mRNA expression in postmortem human overdose victims and rodent models of
addiction
The number of studies examining the effects of cocaine on one or a small number of
genes dwarf the number of genome-wide expression studies. A number of comprehensive
analyses, primarily using microarray, of cocaine-induced gene expression have been published
over the years, in both animal models and human postmortem brain. These studies highlight
the importance of components of the extracellular matrix, including cadherins, integrins, and
matrix metalloproteinases109-112. In addition to the extracellular changes that occur in synapse
formation, a significant body of work has focused on the role of actin cytoskeletal
rearrangements, mediated in large part by the Rho-family of proteins, in the neural plasticity
of drug abuse68,98,109,113-116. A variety of signaling molecules and receptors have also been
implicated in the molecular responses of the brain to cocaine. Examples include the synaptic
vesicle associated proteins α-synuclein and synaptotagmin, clathrin, several dopamine
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receptors and the dopamine transporter, a number of ionotropic and metabotropic glutamate
receptors, opiate receptors and opiate peptides, other neuropeptides, second messenger
molecules such as the mitogen-activated protein kinases (MAPKs), calmodulin proteins,
Ca2+/calmodulin-dependent protein kinases, other kinases, phosphatases, and a number of
different transcription factors30,117-122. Despite decades of dedicated work, a complete picture of
the gene expression changes that accompany cocaine exposure and withdrawal remains
elusive.

microRNAs and their emerging role in cocaine research
Several recent studies have investigated the role of AGO2 and miRNAs in biochemical
and behavioral responses to cocaine exposure123-127. For example, qPCR and in situ analysis of
specific bioinformatically-determined miRNAs identified let-7d, miR-124, and miR-181a as
cocaine-regulated in rats123,127. Two studies by the Kenny group identified induction of miR-132
and miR-212 in dorsal striatum after 7 days of cocaine self-administration in rats and implicate
miR-212 in the behavioral and motivational response to cocaine through CREB, MeCP2, and
brain derived neurotrophic factor (BDNF) signaling124,125. In addition, Schaefer et al. identified
an overlapping subset of cocaine-induced and AGO2-knockdown-depleted miRNAs in D2
dopamine receptor expressing neurons of the NAc, showing reduced cocaine selfadministration when AGO2 is depleted from D2 receptor expressing neurons126.
Together, these studies provide evidence that miRNA-mediated gene regulation plays
an important role in the cocaine response. However, all of these studies were targeted to a
small number of candidate miRNAs or used microarrays, which suffer from issues that plague
microarray studies; these include cross-hybridization, high background signal, low dynamic
range, and the inability to identify unknown miRNAs3, and thus these studies may not provide
a complete picture of cocaine-induced changes in miRNA levels.
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Proteomics and drug abuse research
Very few proteomic studies have looked at quantitative changes in postsynaptic
proteins following exposure to drugs of abuse128. In one of the only drug-respone proteomic
studies to date, Devi and colleages examined changes in the hippocampal postsynaptic
proteome of mice after morphine injection, identifying just over 100 differentially regulated
proteins129. They uncovered changes to a variety of proteins involved in mRNA and protein
trafficking, intracellular signaling, rearrangement of the actin cytoskeleton, and other aspects
of synaptic plasticity. They found significant upregulation of clathrin in the postsynaptic
compartment after morphine, suggesting a role for the endocytic pathway in the response to
drugs of abuse129.
Another recent study in rhesus monkeys used a combined proteomic approach to
identify cocaine-regulated changes in cytosolic proteins from the NAc130. They uncovered
cocaine-altered expression of proteins with known roles in the control of cell morphology,
signal transduction, and synaptic plasticity, as well as components of the AMPA and NMDA
receptor signaling complexes. They also looked for differentially regulated phosphorylation
after cocaine, finding 15 proteins with increased phosphorylation following cocaine, including
structural, signaling, and metabolic proteins130.

The future of drug abuse research
Knockout and transgenic mouse models have been invaluable for investigations into
the behavioral, biochemical, and molecular effects mediated by single genes. It is becoming
increasingly clear, however, that the changes that occur as a result of drug abuse are
incredibly widespread, affecting multiple brain regions and cell-types in a system-wide
manner. These global studies emphasize the broad effects of drug exposure on neuronal gene
expression, underscoring the need for an integrative approach that combines mRNA, miRNA,
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and protein expression profiling in combination with focused single gene studies and
innovative behavioral paradigms in the quest to uncover what drives addiction and develop
integrated therapeutic approaches.

A similar version of the preceding chapter was published as a review:
Eipper-Mains, J.E., Eipper, B.A., Mains, R.E. Global Approaches to the Role of miRNAs in
Drug-Induced Changes in Gene Expression. Front Genet 3, 109 (2012).

CHAPTER 2
Cocaine-regulated expression of striatal microRNAs
The following is a duplicate version of a published manuscript:
Eipper-Mains, J.E.*, Kiraly, D.D., Palakodeti D., Mains, R.E., Eipper, B.A., Graveley B.R. RNA 17,
1529-1543 (2011).

Abstract
MicroRNAs (miRNAs) are small RNAs that modulate gene expression by binding target
mRNAs. The hundreds of miRNAs expressed in the brain are critical for synaptic development
and plasticity. Drugs of abuse cause lasting changes in the limbic regions of the brain that
process reward, and addiction is viewed as a form of aberrant neuroplasticity. Using nextgeneration sequencing, we cataloged miRNA expression in the nucleus accumbens and at
striatal synapses in control and chronically cocaine-treated mice. We identified cocaineresponsive miRNAs, synaptically-enriched and depleted miRNA families, and confirmed
cocaine-induced changes in protein expression for several predicted synaptic target genes.
The miR-8 family, known for its roles in cancer, is highly enriched and cocaine-regulated at
striatal synapses, where its members may affect expression of cell adhesion molecules.
Synaptically-enriched cocaine-regulated miRNAs may contribute to long-lasting drug-induced
plasticity through fine-tuning regulatory pathways that modulate the actin cytoskeleton,
neurotransmitter metabolism, and peptide hormone processing.

Introduction
Hundreds of microRNAs (miRNAs), a class of endogenous 21-25 nucleotide small RNAs
that modulate gene expression by binding complementary sequences in the 3’-untranslated
regions (3’-UTRs) of their target mRNA transcripts36, are expressed in the mature mammalian
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brain37-40 and are thought to be involved in synapse development and plasticity41. The
biogenesis of mature miRNAs is characterized by successive RNA cleavage events in which
long primary miRNA (pri-miRNA) transcripts are processed into shorter preliminary miRNA
(pre-miRNA) hairpins, exported from the nucleus, and cleaved into ~22 nt duplex RNAs prior
to being loaded into RNA-induced silencing complexes (RISCs)36. Each RISC contains an
Argonaute protein (AGO1-4 in human and mouse), and a miRNA42. The RISC then interacts
with the target mRNAs through base pairing interactions specified by the miRNA, and either
represses translation or induces mRNA degradation. AGO2, the only catalytically active AGO
family member in humans and mice, has endonuclease (‘slicer’) activity and the ability to
cleave target mRNAs36.
Exposure to drugs of abuse such as cocaine triggers persistent cellular and molecular
changes in the limbic regions of the brain that process reward. The limbic system, in particular
the striatum, is considered the epicenter of the long-term molecular and morphological
changes that underlie addiction79. The ventral striatum (nucleus accumbens) is considered the
primary striatal subregion with limbic functions. Neurons can modulate gene expression with
subcellular precision; polyribosomes and mRNAs are found at the base of dendritic spines and
are involved in localized protein synthesis43,44. Both AGO2 and DICER, an RNase III enzyme
required for miRNA biogenesis, have been localized to dendritic spines47. Emerging evidence
supports an autonomous role for individual synapses in the local control of protein translation
coupled to neuronal excitation41,45.
Data from broad expression studies using microarray technology and from focused
single-gene approaches indicate that cocaine exposure elicits widespread changes in the
transcriptional landscape87. Several recent studies have begun to investigate the role of AGO2
and miRNAs in the biochemical, molecular, and behavioral response to cocaine123-126. For
example, qPCR and in situ analysis of specific bioinformatically-determined miRNAs identified
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let-7d, miR-124, and miR-181a as cocaine-regulated in rats123. Two studies by the Kenny group
identified induction of miR-132 and miR-212 in dorsal striatum after 7 days of cocaine selfadministration in rats and implicate miR-212 in the behavioral and motivational response to
cocaine through CREB, MeCP2, and BDNF signaling124,125. In addition, Schaefer et al. identified
an overlapping subset of cocaine-induced and AGO2-knockdown-depleted miRNAs in D2
dopamine receptor (Drd2) expressing neurons of the NAc, and showed a reduction in cocaine
self-administration when AGO2 is depleted from Drd2 neurons126. Consistent with these
findings, we observed cocaine-induced increases in Ago2 mRNA levels upon performing RNASeq (JEE-M et al. in preparation). Together, these studies provide evidence that miRNAmediated gene regulation plays an important role in cocaine-related changes in
neurotransmission and behavior. However, all of these studies were targeted to a small
number of candidate miRNAs or used microarrays, which suffer from issues of crosshybridization, higher background signal, lower dynamic range, and lack the ability to identify
unknown miRNAs3, and therefore do not provide a complete picture of cocaine-induced
changes in miRNA levels.
Here, we have more closely examined the role of AGO2 and miRNAs in response to
chronic cocaine exposure. First, we confirmed synaptic Ago2 mRNA and protein expression in
the striatum and increased expression upon chronic cocaine exposure. We also determined
the repertoire of miRNAs expressed in total nucleus accumbens (NAc) tissue lysates and
purified striatal postsynaptic densities (PSDs) harvested from saline- and cocaine-treated mice.
This led to the identification of a subset of cocaine-regulated miRNAs in whole tissue and at
the synapse, and the characterization of miRNAs by degrees of synaptic enrichment and
depletion. We also identified mRNAs that are potentially targeted by the differentially
expressed miRNAs, and validated cocaine-induced changes in protein levels for several of the
identified targets. These data provide an overview of the global regulation and synaptic
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enrichment of miRNAs in response to cocaine.

Results
Cocaine regulates striatal AGO2
To assess whether AGO2 protein was present at striatal synapses, we subjected adult
mouse striatum to subcellular fractionation (Fig. 2.1A). Strong enrichment of NR2B, an NMDA
receptor subunit, in the PSD fraction, and depletion of Synaptophysin, a presynaptic protein,
verified the success of the preparation131-133. The ER lumenal protein BiP showed strong
enrichment in the ER and Golgi fraction. βIII-tubulin was most abundant in the cytoplasmic
fractions. Likewise, the striatally-enriched cytoplasmic protein DARPP32134 was highly enriched
in soluble fractions and was absent from synaptic fractions. As expected, AGO2 was enriched
in the ER/Golgi fraction and present in the cytoplasmic fractions. Consistent with prior studies
demonstrating synaptic localization of AGO2 in hippocampus and frontal cortex47,135, our data
indicate that AGO2 was present in striatal PSDs (Fig. 2.1A).
We next used quantitative-PCR to examine whether chronic cocaine administration
affected Ago2 mRNA expression in the ventral striatum and found a significant increase in the
level of Ago2 mRNA following cocaine exposure (Fig. 2.1B). We then determined the impact of
chronic cocaine on AGO2 protein levels at the PSD. Striata (dorsal and ventral) and medial
prefrontal cortices (mPFCs) from 12 cocaine-treated and 12 saline-treated wild-type male
C57BL/6 mice were pooled and subjected to subcellular fractionation. Levels of AGO2 and βIIItubulin in PSDs purified from striata and mPFCs were assessed by quantitative Western
blotting. We observed a 24% increase in synaptic AGO2 protein after cocaine treatment in the
striatum, but not the mPFC (Fig. 2.1C,D). Together these results indicate that AGO2 is localized
to the striatal PSD and increases after cocaine treatment. Because up-regulation of AGO2 was
specific to the striatum, we chose to focus our subsequent analyses on this brain region.
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Figure 2.1 Subcellular fractionation
(A) Wildtype mouse striata were subjected to subcellular fractionation. Aliquots containing equal
amounts of protein (10µg; 5µg, PSD) were fractionated by SDS-PAGE, transferred, and analyzed by
Western blot. NR2B, AGO2, and Synaptophysin were visualized from one gel; BiP, βIII-tubulin, and
DARPP32 were visualized from an identical gel. PSD, postsynaptic density. (B) Total NAc RNA from adult
male mice treated with saline or cocaine (4 per group) was analyzed by qPCR; Ago2 mRNA expression
was normalized to GAPDH. (C,D) PSDs purified from the striata (C) and PFCs (D) of saline (S)- and cocaine
(C)-treated mice were fractionated by SDS-PAGE. AGO2 levels were normalized to βIII-tubulin by
densitometry for the varying amounts of protein loaded; plot shows average C/S ratio for AGO2.
Significance was tested by the 2-tailed Student's t-test with unequal (B) or equal (C,D) variance. *P <
0.05; **P < 0.01.
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The nucleus accumbens and purified striatal PSDs share abundant microRNAs
Given the synaptic localization and cocaine responsiveness of AGO2 protein, we
hypothesized a role for AGO2 and miRNAs in regulating mRNA stability or translation at the
striatal PSD in response to cocaine. To explore this idea, we used next-generation sequencing
to analyze the global miRNA expression profiles in both NAc total lysates and purified striatal
PSDs. For the NAc lysates, we sequenced 2.53 and 4.46 million reads from the saline and
cocaine samples, respectively (Table 2.S1). We also generated 3.67 and 4.60 million reads from
the striatal PSD saline and cocaine samples, respectively (Table 2.S1). After removing the 3’
linker sequence, reads ranging from 18-30 nt were aligned to the miRBase database (version
16)136,137 using Bowtie (version 0.12.7)24 to identify and assess the abundance of known
miRNAs.
We generated pairwise scatter plots to compare expression of each mature miRNA (as
a percentage of total reads) across all four samples (Fig. 2.2A). The two NAc total lysate
samples correlated more closely with each other (R2 = 0.97) than with either striatal PSD
sample (R2 = 0.90-0.93). The converse was also true, with striatal PSD miRNAs exhibiting a
higher correlation to one another (R2 = 0.97) than to the NAc samples. For both the total tissue
lysates and the PSDs, a handful of individual miRNAs appeared to be cocaine-regulated;
cocaine treatment did not cause widespread alterations in the global miRNA profile.
While the total tissue lysate and purified PSD expression profiles differed, the most
highly expressed miRNAs were largely identical; 11 of the 15 most abundantly sequenced
miRNAs in both groups were the same (Fig. 2.2B,C). Of note, a number of miRNAs known to be
brain-specific or neurally-enriched, such as miR-9, miR-30, miR-127, miR-138, miR-181, and let737-40, were very abundant in these samples.
We detected one or more reads mapping to a total of 500 (74%) of the 672 mouse pre-
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Figure 2.2 High-throughput sequence analysis of NAc and PSD miRNA
(A) Pairwise scatter plots of miRNA expression data for NAc lysate and striatal PSD libraries (Saline and
Cocaine) prepared from adult mouse; shown as log10(normalized miRNA frequency) per sample. R2
values were calculated by least squares best fit. Expression data for the 15 most abundant miRNAs in
NAc lysates (B) and striatal PSDs (C) are shown as reads (adjusted for equal total reads per sample). The
miRNAs in black italics are highly expressed in both NAc and PSD; miRNAs in red italics are highly
expressed only in that sample.

Classification of miRNAs detected by RNA-Seq
miRBase v16

All data

NAc lysates

Striatal PSDs

pre-miRNAs

672

500 (280)

475 (242)

476 (264)

mature miRNAs

1055

771 (342)

718 (283)

732 (312)

miRNA families

253

222 (159)

214 (137)

216 (147)

miRNAs in families

502

410 (266)

392 (230)

394 (253)

Table 2.1 Classification of miRNAs detected by RNA-Seq
Number of pre-miRNAs, mature miRNAs, miRNA families, and miRNAs in families detected by RNA-Seq
at one or more reads and 100 or more reads (in parentheses).
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miRNAs annotated in miRBase, of which 475 and 476 miRNAs were detected in the NAc and
striatal PSD libraries, respectively (Table 2.1). We set a lower limit of 100 reads per miRNA for
further analysis since we found that reliable qPCR validation of changes necessitated this level
of expression. Although this read requirement decreased the diversity of miRNAs considered
for further analysis, the miRNAs meeting the expression cut-off account for 99.7% and 99.8%
of all reads in the NAc and striatal PSD libraries, respectively. A summary of the individual
miRNAs and miRNA families identified in these experiments is presented in Table 2.1.

Cocaine modulates expression of ventral striatum microRNAs
There were 283 mature miRNAs detected with at least 100 reads in both NAc lysate
libraries (Table 2.1); 10% of these miRNAs exhibited at least a 1.5-fold change in expression,
with 16 miRNAs up-regulated and 13 down-regulated after cocaine treatment. The NAc total
lysate miRNAs that exhibit the largest changes in expression following cocaine are shown in
Fig. 2.3A. The regulated miRNAs were generally of low- to moderate-abundance, detected at a
level between 100 and 1000 reads. One notable exception, miR-29b, was among the 15 most
abundantly expressed miRNAs in the NAc (Fig. 2.2B).
We used qPCR to validate cocaine-induced changes in several of the most highly
regulated miRNAs and to validate RNA-Seq data for miRNAs known to be brain-enriched or
synaptically-relevant. Commercially available probes were used for qPCR; these probes
measure only one mature miRNA product, which did not always correspond to the most
abundantly sequenced product due to 3’-end heterogeneity (Fig. 2.4). Nevertheless, strong
agreement across the two methods (r = 0.68) was observed when the cocaine/saline ratios
obtained by qPCR and RNA-Seq were plotted (Fig. 2.3B). Importantly, inter-platform
agreement was consistent over a broad range of overall expression levels.
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Figure 2.3 Cocaine-regulated miRNAs in NAc total lysates
(A) NAc lysate libraries (Saline and Cocaine) analyzed by high-throughput sequencing of miRNAs. The
eight most cocaine down- and up-regulated miRNAs detected at >100 reads are shown as adjusted
reads (equal total reads per sample) on log10 scale. The number above the bars indicates fold change. (B)
Pairwise scatter plot comparing log10 ratio of Coc/Sal expression for selected miRNAs in NAc tissue
lysate as computed from RNA-Seq data (vertical axis) and qPCR data (horizontal axis). Size of circle is
proportional to average RNA-Seq expression value. Pearson’s Coefficient represents the linear
correlation coefficient, r.
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Figure 2.4 3’-end heterogeneity and varying RNA-Seq read abundance
Expression data across all samples are shown as reads (adjusted for equal total reads per sample) for
sequences mapping to miR-132 and miR-143. Arrowhead () marks annotated mature miRNA sequence
from miRBase version 16. Commercially available qPCR primers amplify sequence marked by
arrowhead.
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Cocaine regulates microRNAs in striatal PSDs
A specific subset of mRNAs is transported along dendrites and local protein synthesis
occurs in stimulated dendritic spines, altering the components of the synapse43,44. Since AGO2
protein is localized to the PSD and its levels at the PSD increased following chronic cocaine
exposure, we determined whether any PSD localized miRNAs were responsive to cocaine.
There were 312 mature miRNAs detected at 100 reads or more in both striatal PSD libraries
(Table 2.1); 11% of these miRNAs exhibited at least a 1.67-fold change in expression, with 4times as many miRNAs down-regulated (28) as up-regulated (7) after cocaine treatment. Fig.
2.5A shows those striatal PSD miRNAs with at least 100 reads that demonstrated the largest
change in expression following cocaine. Similar to what was observed for the NAc miRNAs, the
cocaine-regulated PSD miRNAs were generally of low- to medium-abundance, detected with
100 to 10,000 reads.
We again turned to qPCR to confirm responses observed with RNA-Seq. A comparison
of the ratios of cocaine/saline measured by RNA-Seq and qPCR showed a high degree of
concordance between the two techniques (r = 0.76) (Fig. 2.5B). Cross-platform agreement
spanned a very broad range of expression levels, as seen in NAc lysates.

Synaptically-enriched microRNA families
To determine the subset of miRNAs that are enriched or depleted at the synapse, we
calculated the relative abundance of each miRNA in all four samples. We then computed the
average abundance of each miRNA in the two NAc lysate and striatal PSD samples, and
calculated the log10 ratio of the PSD average over the NAc average. The miRNAs with higher
PSD-to-NAc lysate ratios are synaptically-enriched (Fig. 2.6), while those with lower ratios are
synaptically-depleted (Fig. 2.7). Z-scores of relative expression were calculated for each
sample and the data displayed as heat maps (Fig. 2.6A,B).
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Figure 2.5 Cocaine-regulated miRNAs in striatal PSDs
(A) Striatal PSD libraries (Saline and Cocaine) analyzed by high-throughput sequencing of miRNAs. The
eight most cocaine down- and up-regulated miRNAs detected at >100 reads are shown as adjusted
reads as described in Fig. 3. (B) Pairwise scatter plot comparing log10 ratio of Coc/Sal expression for
selected miRNAs in striatal PSDs as computed from RNA-Seq data (vertical axis) and qPCR data
(horizontal axis) as described in Fig. 2.3.
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Figure 2.6 Identification of miRNA families enriched at the PSD
(A) Normalized miRNA frequency data for saline- and cocaine-treated NAc lysate and striatal PSD
libraries of wildtype mice were calculated; heat map is sorted by decreasing average PSD
frequency/NAc frequency ratio. Z-score was computed on normalized miRNA frequency across all
samples. Blue indicates low expression and yellow indicates high expression. (B) Expansion of heat map
showing top PSD-enriched miRNAs. Text color indicates miRNA families with 2 or more family members
appearing in the list.
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Of the 672 annotated murine miRNAs, 75% (502) can be grouped into 253 families
based on sequence homology in the ‘seed region’ (nts 2-8 at the 5’-end of the miRNAs) and
the observation that these miRNAs are often functionally redundant36. We detected expression
of at least one member of 222 (88%) of the 253 annotated miRNA families, with 159 families
expressed at 100 reads or more (Table 2.1). Strikingly, several of the synaptically-enriched
miRNAs we identified were members of the same family, as indicated by text color in Fig. 2.6B.
All 5 members of the miR-8 family (miR-141, miR-200a, miR-200b, miR-200c, and miR-429) were
synaptically-enriched. The same was true for the miR-7 and miR-142 families. The mouse
genome contains 12 loci encoding members of the let-7 family, three of which were
synaptically-enriched (Fig. 2.6B). In contrast, we did not observe family enrichment in the
subset of PSD-depleted miRNAs (Fig. 2.7).

PSD-localized, cocaine-regulated microRNAs target a functionally-related subset of
mRNAs
To provide insight into the role of the cocaine-regulated miRNAs, we performed a
computational search for potential target mRNAs. First, we compiled a list of 1,041
dendritically- and synaptically-localized mRNAs reported in the literature138-143 (Table 2.S4).
424 of those mRNAs were PSD-enriched in rat forebrain by microarray143, and this subset of
synaptically-localized genes (Table 2.S4) was cross-referenced with the putative miRNA target
genes identified by analysis using the miRanda microRNA target prediction algorithm144,145.
Briefly, each predicted miRNA binding site in the 3’-UTR of a given gene has a pre-computed
mirSVR score; this value directly correlates with the extent of mRNA down-regulation
predicted by miRNA binding, and the composite score for each gene in Fig. 2.8 represents the
sum of all cataloged mirSVR scores across the queried miRNAs145.
We performed target prediction on the 16 PSD-localized cocaine-regulated miRNAs
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Figure 2.7 miRNAs depleted at the PSD
(A) High-throughput sequencing data for saline- and cocaine-treated NAc lysates and striatal PSDs of
wildtype mice; normalized miRNA frequency was calculated and heat map is sorted by decreasing
average PSD frequency/NAc frequency ratio (as in Fig. 2.6). Z-score was computed on normalized
miRNA frequency across all samples. Blue indicates low expression and yellow indicates high
expression. (B) Expansion of heat map showing top PSD-depleted miRNAs. Text color indicates miRNA
families with more than two miRNAs appearing in the list.
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Figure 2.8 Target prediction for cocaine-regulated miRNAs
The 16 most cocaine-regulated striatal PSD miRNAs from Fig. 4.6 were subjected to bioinformatic target prediction using miRanda. The list of potential
target mRNAs was cross-referenced with the 424 PSD-enriched mRNAs identified by Suzuki et al. 2007 (Table S4) and sorted by ascending mirSVR score.
symbols show presence of predicted miRNA binding site in 3’-UTR of target gene; number of signs denotes number of predicted miRNA binding sites.
The 36 target genes shown were run through gene ontology (GO) analysis using DAVID; colored boxes indicate enriched GO functions with P < 0.05.
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depicted in Fig. 2.5A. A subset of the list of synaptically-localized predicted target genes for
the cocaine-regulated striatal-PSD miRNAs sorted by mirSVR score is shown in Fig. 2.8. A
number of the identified target genes were predicted to have multiple binding sites for a
given miRNA in their 3’-UTR (depicted by the number of Æ symbols) and the majority of the
predicted target genes had putative binding sites for both up- and down-regulated miRNAs.
We carried out gene ontological analysis using DAVID28,146,147 to investigate the
functional properties of the identified target genes. The colored boxes next to the genes in
Fig. 2.8 show the enriched gene ontological categories (P < 0.05). Most of the enriched
categories (cell junction, regulation of synaptic transmission, calcium ion binding,
dendrite/neuron projection, cell-cell signaling, cytoskeleton, phosphate metabolic process,
transmembrane, growth factor binding) are processes generally linked to synaptic plasticity,
learning, and memory.

Identified target genes exhibit differential expression at striatal synapses after
cocaine
Schematic drawings for Ntrk2, E-cadherin, Mtdh and Pcsk2, potential target genes of
cocaine-regulated synaptic miRNAs (Fig. 2.9), depict the sites within their annotated 3’-UTRs
that are predicted to bind up- and down-regulated miRNAs. Since these synaptically-enriched
transcripts may interact with multiple regulated miRNAs, the direction of cocaine-mediated
changes in synaptic protein levels are difficult to predict.
We used quantitative Western blotting to investigate the effect of cocaine
administration on the protein level of several potential target genes of cocaine-regulated
synaptic miRNAs (Fig. 2.9). One identified target gene is Ntrk2 (also known as TrkB), a member
of the neurotrophin receptor tyrosine kinase family, which binds brain-derived neurotrophic
factor (BDNF) and is critically involved in the process of activity-dependent synaptic plasticity
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and long-term potentiation (LTP)148. The Ntrk2 3’-UTR is targeted by four miR-8 family members
(miR-200a, miR-200b, miR-200c, and miR-429), which are down-regulated by cocaine, and by
miR-33 and miR-130b, which are up-regulated by cocaine (Fig. 2.8). The level of synaptic TRK
protein increased 18% in the striatum after chronic cocaine administration (Fig. 2.9A).
Similarly, synaptic expression of Metadherin (MTDH), encoded by Mtdh, the top
synaptically-regulated miRNA target gene (Fig. 2.8), increased to 142% of the saline level after
chronic cocaine treatment (Fig. 2.9B). Mtdh is targeted by miR-183 and four miR-8 family
members, which are down-regulated by cocaine, and by miR-16, miR-32, miR-33, miR-130b, and
miR-153, which are up-regulated by cocaine (Fig. 2.8). While not a direct target of the
identified cocaine-regulated synaptically-localized miRNAs, E-cadherin (also known as Cdh1 or
ECAD) expression is controlled by transcriptional repressors (ZEB1 and ZEB2) which are directly
targeted by members of the miR-8 family of miRNAs149, and by several other miRNAs which are
down-regulated by cocaine and by a number of miRNAs which are up-regulated by cocaine
(Fig. 2.9B). Two forms of ECAD were detected at the synapse by Western blot (Fig. 2.9B). The
105 kDa major band is mature ECAD (black arrow) and the higher molecular weight band
represents proECAD150,151. The level of mature ECAD decreased to 68% of the saline level
following chronic cocaine.
The prohormone convertase PC2 (also known as Pcsk2) was also identified in our
bioinformatic analysis as a potential target of the cocaine-regulated miRNAs. Pcsk2 is targeted
by three miR-8 family members and miR-370, which are down-regulated by cocaine, and by
miR-32 and miR-218, which are up-regulated by cocaine (Fig. 2.8). Several forms of PC2 were
detected at striatal PSDs by Western blot (Fig. 2.9C). The smaller molecular weight band
represents mature PC2, the middle band represents proPC2 and the upper band is the size of
preproPC2152, indicative of dendritic synthesis and processing. When normalized to βIII-
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Figure 2.9 Validation of target predictions
(A,B) PSDs purified from the striata of saline (S)- and cocaine (C)-treated mice were fractionated by SDSPAGE; three different amounts of protein were analyzed to establish response linearity. Levels for panTRK (a), ECAD (), and MTDH (b), and PC2 (), proPC2 (), and preproPC2 () (C) were normalized to
βIII-tubulin by densitometry for the varying amounts of protein loaded; plot shows average C/S ratio.
Based on published reports, the higher molecular weight band (~120 kDa) above the major 105 kDa
ECAD band corresponds to the precursor, proECAD ()150,151. For PC2, the smaller molecular weight
band represents mature PC2 (), the middle band represents proPC2 () and the upper band is the size
of preproPC2 ()152. Schematic drawings represent mRNAs of indicated genes; open reading frame
(ORF) is gray, 3’-UTR is striped, arrowheads show miRanda predicted miRNA binding sites for miRNAs
up-regulated () or down-regulated () after cocaine at PSD. Significance was tested by the 2-tailed
Student's t-test with equal variance. *P < 0.05; **P < 0.01.
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tubulin, mature PC2 and proPC2/preproPC2 increased significantly, 67% and 61%,
respectively, after cocaine treatment.

Discussion
The role of miRNAs in response to drugs of abuse is largely unknown. Here, we used
deep sequencing to identify miRNAs that are differentially regulated in response to cocaine
exposure, both in purified NAc tissue and at striatal synapses. This catalog of synaptically
enriched and cocaine-regulated miRNAs provides new insight into the molecular mechanisms
of the cocaine-response and serves as a resource for future studies.
Intriguingly, many (18) of the synaptically-enriched miRNAs we identified are encoded
in miRNA clusters – precursor transcripts that contain multiple miRNAs – or are members of
the same miRNA families. Moreover, the expression patterns of the clustered miRNAs are
similar to one another. Particularly strong examples include the two clusters encoding miR-8
family members (miR-429/200a/b and miR-141/200c), the cluster encoding let-7 family
members (let-7f/miR-98), and clusters miR-1/133a, miR-182/96/183, and miR-216a/217 (Fig.
2.10). This indicates that many of the miRNAs we identified are coordinately regulated by
virtue of being encoded in clusters and potentially control the same set of mRNA targets as
they share the same seed sequences.
It is well established that the growth and remodeling that occur in dendritic spines
following synaptic activity require de novo protein synthesis, and that blocking protein
synthesis attenuates formation of long-term memory41. The ability to modulate the synthesis
of a subset of synaptic proteins affords neurons the capacity to integrate and fine-tune
extracellular cues with subcellular resolution, in individual dendrites or at specific synapses153.
MicroRNAs represent ideal candidates for regulating local translation of specific mRNAs at the
synapse. It is therefore intriguing that we observed both increased levels of synaptically
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Figure 2.10 Analysis of miRNA clusters and families
Heat map shows expression of striatal PSD-enriched miRNAs and accompanying members of their
genomic cluster; “chr” denotes chromosomal location of each miRNA cluster. Normalized miRNA
frequency was calculated from high-throughput sequencing data; Z-score was computed on
normalized miRNA frequency across all samples. Blue indicates low expression and yellow indicates
high expression. Text color identifies miRNA families with two or more miRNAs; bold text indicates
presence in PSD-enrichment list from Fig. 5; gray italic text indicates miRNAs not enriched at striatal
PSD and/or not belonging to listed miR families.
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Figure 2.11 Comparison of data for striatum and cortex/hippocampus
(A) Pairwise scatter plot comparing miRNA synaptic enrichment ratios from Lugli et al., 2008 (adult
mouse cortex and hippocampus; measured by microarray) with RNA-Seq data (adult mouse striatum)
from these experiments. Horizontal axis, data from Lugli et al., 2008 computed as ratio of PSD (Syn)/total
tissue (Tot) expression; vertical axis, data from RNA-Seq computed as PSD/NAc lysate ratio of average of
saline and cocaine expression levels for adult mouse striatal PSD and NAc lysate. Blue circles were
identified as cocaine-regulated and/or were assayed by qPCR, green circles indicate miRNAs enriched at
striatal PSDs by RNA-Seq, red circles indicate miRNAs depleted at striatal PSDs by RNA-Seq, and gray
circles represent all other miRNAs. Size of circle is proportional to average RNA-Seq expression value. (B)
Synaptosomal enrichment and depletion categories for miRNAs from Siegel et al., 2009 as determined
by microarray analysis of rat forebrain samples. Heat map shows high-throughput sequencing data for
saline- and cocaine-treated NAc lysates and striatal PSDs of wildtype mice; normalized miRNA frequency
was calculated and Z-score was computed on normalized miRNA frequency across all samples. Blue
indicates low expression and yellow indicates high expression.
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localized AGO2 protein and altered levels of specific miRNAs upon cocaine exposure. These
observations indicate that modulations in miRNA-mediated gene regulation play an important
role in the response to cocaine. Programmed changes in miRNA levels may result in specific
changes in the stability and/or the translation rate of target mRNAs at the synapse.
We identified several miRNAs that were synaptically enriched or depleted (Fig.
2.6B,2.7B). A comparison of our data to earlier microarray experiments performed in adult (2month old) mouse cortex and hippocampus135 (Fig. 2.11A) revealed significant overlap.
Notably, 4 of the 5 miR-8 family members (miR-200a/b/c/429) are highly enriched in both
datasets. Additionally, miR-182 and miR-183 are highly PSD-enriched in both datasets while
miR-126, miR-143, miR-145, miR-150, and miR-451 are synaptically depleted in both datasets
(Fig. 2.11A). We also observed strong agreement between our data and a second microarray
study that identified synaptosomally-enriched and depleted miRNAs from rat P15 total
forebrain samples52. In both datasets, miR-219-5p, miR-21, miR-377, miR-98, miR-376b, miR-218,
miR-7a/b, and miR-29a are synaptosomally- or PSD-enriched, while miR-143, miR-145, and miR150 are depleted (Fig. 2.11B). The high degree of concordance between these three datasets,
which used different experimental platforms and strikingly different samples, may reflect the
prevalence of glutamatergic synapses and other features common to these brain regions.
The increased levels of AGO2 and altered levels of specific miRNAs at the synapse in
response to cocaine strongly suggest that these factors play a role in controlling translation of
localized mRNAs. To explore this, we identified potential mRNA targets from a set of PSDenriched mRNAs143 (Fig. 2.8). Due to the fact that most mRNAs we identified are predicted to
be targeted by many of the regulated miRNAs, it was difficult to predict whether translation of
the targets would increase or decrease in response to cocaine. Nonetheless, we confirmed
changes in protein levels for three predicted targets (TRKB, MTDH, and PC2) and one indirect
target (ECAD) upon exposure to cocaine. One of the validated targets, TRKB (NTRK2), has also
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been shown to increase in the NAc of rats after chronic cocaine self-administration154, and
TRKB-BDNF signaling in the NAc may modulate behavioral responses to cocaine155.
Importantly, several other predicted targets have been implicated in various aspects of the
cocaine response156-158.
Recent studies have demonstrated the importance of miRNAs in the pathophysiology
of several neuropsychiatric disorders and mental retardation syndromes157,158, including
schizophrenia56-58,159, bipolar disorder, Fragile X mental retardation160-162, Rett syndrome61,
Alzheimer’s disease, Parkinson’s disease163, and Huntington’s disease55. A number of the
cocaine-responsive miRNAs identified in this study are important in controlling dendritic
morphology; these miRNAs, and many others, may contribute to long-lasting forms of drugmediated synaptic plasticity through control of regulatory pathways that modulate changes
to the actin cytoskeleton, neurotransmitter metabolism and peptide hormone processing. It is
likely that the miRNAs we identified are but one aspect of an exquisitely complex regulatory
system which includes dendritic mRNA trafficking and excitation-coupled modulation of
translation and protein phosphorylation to fine-tune translation of synaptically-localized
miRNAs. As the breadth of information about the molecular changes that occur in the brain in
response to cocaine and other drugs of abuse increases, the importance of integrating these
data in a meaningful and biologically informative way becomes increasingly clear.

Methods
Cocaine treatment of mice
Adult wild-type C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine; 2-5 months
old) were used for these experiments. All mice were allowed to acclimate to the colony for at
least one week before handling or injections. Mice were kept in the University of Connecticut
Health Center animal facility on a 12 h light/dark cycle (lights on 7:00 am to 7:00 pm) and
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handled in accordance with University of Connecticut Health Center Institutional Animal Care
and Use Committee guidelines. To reduce stress from handling during the injections, animals
in all groups were handled for 1min/animal/day for 2-3 days prior to the start of injections.
During injections, animals were brought into the behavior room to acclimate to the new
environment for 45-60 minutes each day before the beginning of experiments.
For these studies, we used two slightly different cocaine injection paradigms, both of
which have been shown to produce robust locomotor sensitization. For all experiments,
animals were given a saline or cocaine injection and had their locomotor activity monitored
for the subsequent 45 minutes. In the experiments in which RNA from NAc lysates was used
for miRNA-Seq library preparation, animals were given injections of 20 mg/kg cocaine or saline
(10 ml/kg) intraperitoneally for 7 days. Our group and others have demonstrated the efficacy
of this method at eliciting robust locomotor sensitization98,164. For all other experiments (both
RNA and protein), animals received a lower dose of cocaine (10 mg/kg) on the first and last
(7th) day, with the standard 20 mg/kg cocaine dose on days 2-6165,166. The extent of locomotor
sensitization was taken as the ratio of activity on day 7/day 1166. We chose to switch to this
method because it provided a clearer distinction between those animals that had sensitized
and those that did not. Protein biochemistry from our laboratory has shown no biochemical
differences between sensitized animals from the two paradigms (DDK, unpublished
observations). Neither tissue nor data from these different treatment paradigms were pooled.
For all experiments, animals were sacrificed 24 hours after the final injection.

Whole tissue lysate preparation and subcellular fractionation
Adult male mouse ventral striatum (nucleus accumbens, NAc) punches were
harvested. For whole tissue protein studies, samples were sonicated and boiled in 1% SDS,
50mM TrisHCl [pH 7.4], 5mM EDTA, 50mM NaF, 2mM sodium orthovanadate, 1mM PMSF, and
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protease inhibitor cocktail as described133. Total RNA from tissue lysates for individual mice
was prepared from freshly dissected tissue with TRIzol (Invitrogen) following the
manufacturer’s instructions, except that isopropanol precipitation was carried out overnight at
-20°C with 2 ethanol washes instead of one.
For subcellular fractionation, whole striata (40 mg wet weight/mouse) or medial
prefrontal cortices (mPFC) (30 mg/mouse) from 12 identically-treated male mice were pooled,
homogenized and fractionated by differential centrifugation followed by sucrose gradient
centrifugation. After extraction of the PSD-enriched fraction with 0.5% Triton X-100, PSDs were
pelleted and subjected to Western blot analysis as described98,133. The protocol is similar to
that of Lugli et al.135 and was modified to protect against RNA degradation as follows: all rotors,
homogenizers, pestles, and ultracentrifuge tubes were rinsed with RNaseZAP (Applied
Biosystems) and DEPC water and air dried prior to use; fractionation buffers were prepared
using DEPC water and were treated with RNASecure (1:25 dilution from stock; Applied
Biosystems) at 60°C for 10 min; aliquots of different subcellular fractions were diluted into
TRIzol for preparation of total RNA as described above.

Small RNA cloning and sequencing
Small RNA sequencing libraries were prepared following the manufacturer’s
instructions for the Small RNA Sample Prep Kit (Illumina). Total RNA used for NAc tissue lysate
library preparation was pooled in equal parts from RNA isolated from 8 male mice from each
treatment group. One saline and one cocaine NAc lysate library were prepared from the
pooled RNA and these are referred to as NAc lysate saline and cocaine libraries. Total RNA used
for striatal postsynaptic density (PSD) library preparation was isolated as outlined above from
the pooled striata of 11 mice (7 male, 4 female) from each treatment group; these libraries are
referred to as striatal PSD saline and cocaine libraries. Small RNAs of 18-35 nt were gel-purified

47

from 1 µg of pooled total RNA. Eluted RNAs were ligated to 5’ and then to 3’ adaptors with
RNA ligase, with gel purification following each ligation. RNAs were reverse transcribed and
cDNAs were PCR-amplified for 16 cycles. PCR products were purified on a non-denaturing
acrylamide gel and sequenced on the Illumina Genome Analyzer IIx for 50 (NAc lysate libraries)
or 40 (striatal PSD libraries) cycles.

Small RNA genomic analysis
Sequences were extracted from image files using Firecrest and Bustard. The 3’ adaptor
sequences were trimmed from the reads, and reads 18-30 nt in length were aligned to all
annotated mouse microRNAs from miRBase (www.mirbase.org; version 16) with Bowtie24
(bowtie-bio.sourceforge.net; version 0.12.7); only perfectly aligning reads were considered for
miRNA expression level analysis. A custom Perl script was used to calculate the number of
reads aligning to each specific miRNA gene and data were normalized by the total number of
reads obtained in that sequencing run. A cut-off of 100 reads or more for an individual miRNA
was required for it to be included in further expression analyses.
To identify reads mapping to a variety of non-coding genes and repetitive elements,
the remaining non-miRNA sequences were aligned to the Rfam database (rfam.sanger.ac.uk;
version 10.0), the Repbase database (www.girinst.org/repbase/index.html; version 16.01), and
NONCODE (noncode.org; version 2.0). We subsequently mapped the remaining reads to the
mouse transcriptome, including exons, introns, and exon-exon junctions annotated on the
UCSC genome browser (genome.ucsc.edu; mm9; NCBI Build 37) as the following tracks: UCSC
Genes, RefSeq Genes, Vega Protein Coding Annotations, and Ensembl Gene Predictions.
Finally, the remaining reads were aligned to the mouse genomic sequence (genome.ucsc.edu;
mm9; NCBI Build 37). All of these alignments were performed using Bowtie and allowing 1mismatch. Alignment data are shown in Fig. 2.12.
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Figure 2.12 Identification of mapped sequences
After trimming 5’ and 3’ adaptors from extracted sequences for all four libraries, those between 18 and
30 nt in length were aligned to miRBase annotated mouse microRNAs using Bowtie24 (version 0.12.7);
perfect alignment was required. Remaining non-miRNA sequences were aligned to non-coding and
repetitive elements annotated in the Rfam, Repbase, and NONCODE databases, and then to the mouse
transcriptome (exons, introns, exon-exon junctions), and mouse genome. These non-miRNA alignments
were performed permitting 1-mismatch. The percentage of the total reads mapped to each category is
shown graphically in the pie-chart and numerically in tabular form.
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Importantly, the trimmed reads were also aligned to miRBase allowing 1- or 2mismatches. Neither the overall expression pattern nor the list of the most cocaine-responsive
miRNAs changed significantly when allowing for more mismatches (JEE-M, unpublished
observations). Read numbers presented in this paper were calculated from the 0-mismatch
alignment.

Generation of heat maps
Normalized miRNA frequency across all 4 sequenced libraries was calculated;
expression in one sample of 100 reads or more was required. Z-scores were computed from
frequency data using the following equation: (x - µ)/σ; x, sample frequency; µ, mean across all
samples; σ, standard deviation across all samples. Blue indicates low expression and yellow
indicates high expression; heat maps were generated using Java Treeview software
(sourceforge.net/projects/jtreeview/files).

Target gene prediction
MicroRNA target genes were identified using miRanda144,145 (www.microrna.org;
August 2010 release). Prediction scores were computed using the miRanda database of highly
conserved target sites with good mirSVR scores145. We chose this database because programs
requiring target conservation across a broad range of species are more stringent than those
with more relaxed definitions of conservation. For the miRanda-generated target gene list for
PSD-localized cocaine-regulated miRNAs, we filtered the list to include only those target genes
with supporting experimental data indicating dendritic or synaptic localization; data compiled
from six studies138-143 yielded a list of 1,041 target genes (Table 2.S2).

Functional analysis of target genes
We used the Database for Annotation, Visualization, and Integrated Discovery (DAVID;
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david.abcc.ncifcrf.gov) to interrogate multiple databases in parallel with a list of target genes28.
We used the GoCharts module to analyze a subset of the target mRNAs identified from
miRanda analysis. GoCharts uses the classifications of the Gene Ontology Consortium (GO;
www.geneontology.org), which assigns functional terms to annotated genes and proteins.
Only those GO terms identified by DAVID with enrichment P < 0.05 were included in Fig. 2.8.

Quantitative polymerase chain reaction (qPCR)
The cDNAs from tissue lysate total RNA were prepared using iScript (BioRad) with
random primers; a 5 min 65°C step was added to the iScript protocol before chilling and
adding the enzyme. Pairwise statistical comparisons used the t-test for two samples assuming
unequal variance and the two-tailed value are reported. Real-time PCR for mRNAs was
performed using an Eppendorf Realplex2 machine and Sybr-Green (BioRad), with the
following parameters: 95°C 2 min; 95°C 15 sec, 55°C 15 sec, 68°C 40 sec; repeat 40x. Maximal
rates of amplification per cycle were calculated for all primer pairs and all samples in all assays
and averaged 2.03 ± 0.06 (SD) in 6 runs of 96-well plates. Data are calculated with respect to
GAPDH for each sample within an assay, and data across assays were then averaged because
the values with respect to GAPDH for each transcript were very consistent. Primer pairs were
chosen to keep the melt temperature (Tm) between 60 and 62°C (calculated using
www.basic.northwestern.edu/biotools/oligocalc.html) and products in the 120 ± 5 nt size
range. Differences between saline and cocaine samples were evaluated using the 2-tailed
Student's t-test with unequal variances.
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Primers used for mRNA qPCR
Primer name

Sequence

Tm (°C)

Gapdh-for

5’	
   TTGTCAGCAATGCATCCTGCACCACC	
   3’

61

Gapdh-rev

5’	
   CTGAGTGGCAGTGATGGCATGGAC	
   3’

61

Ago2-for

5’	
  GACTATCAGCCAGGAATCACGTTCATCG	
  3’

61

Ago2-rev

5’	
  

62

CCACGGTTGTGCCTGCGGGAATG	
  

Table 2.2 Primers used for mRNA qPCR

3’

Product
length (nt)
119
121
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MicroRNA qPCR
Reverse transcription using mature miRNA-specific primers was performed on 1-10 ng
total RNA from tissue lysates per the manufacturer’s instructions for the TaqMan MicroRNA
Reverse Transcription Kit (Applied Biosystems) using the suggested parameters (ice 5 min;
16°C 30 min; 42°C 30 min; 85°C 5 min). Quantification was performed using the TaqMan
MicroRNA Assay (Applied Biosystems) with the manufacturer’s recommended amplification
parameters (95°C 10 min; 95°C 15 sec, 60°C 60 sec; repeat 40x). NAc lysate qPCR was
performed on RNA isolated from individual animals while striatal-PSD qPCR was carried out on
the pooled preparations. Data are calculated with respect to an empirically determined
endogenous control miRNA; total NAc lysate and striatal-PSD miRNA levels were calculated
with respect to miR-9 and miR-101a, respectively. Normalization data are shown in Fig. 2.13,
and qPCR data for Fig. 2.3B and 2.5B are in Fig. 2.14.
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Figure 2.13 Use of miR-101b for normalization and assessment of brain-enriched and
synaptically-important miRNAs
(A) Expression of miR-101b from NAc tissue lysates from wildtype adult male mice treated with saline
and cocaine was evaluated by RNA-Seq (left) and by qPCR (right). RNA-Seq data for miR-101b are shown
as reads (adjusted, equal total reads/sample) on log10 scale; qPCR data for miR-101b are normalized to
miR-9 on linear scale. (B) Expression of miR-101a and miR-101b in striatal PSDs from saline- and cocainetreated wildtype mice was also evaluated by RNA-Seq (left) and qPCR (right). RNA-Seq data are shown
as reads (adjusted, equal total reads/sample) on log10 scale; qPCR data are shown as the ratio of miR101b/miR-101a expression. Expression of brain-enriched and/or synaptically important miRNAs in NAc
lysates and striatal PSDs by RNA-Seq (C,E) or qPCR (D,F).
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Figure 2.14 Validation of RNA-Seq cocaine-induced expression changes by qPCR
qPCR analysis of cocaine-regulated miRNAs identified in Figures 3 and 4 from NAc lysates (A) and striatal
PSDs (C). (B) Expression of select PSD-expressed cocaine-regulated miRNAs not appearing in Fig. 4A by
RNA-Seq. Significance was evaluated using the 2-tailed Student's t-test with unequal (A) or equal (C)
variance. *P < 0.05; **P < 0.005.

55

Western blot analysis
Gels (4-15% Mini-PROTEAN TGX precast gels, BioRad) of subcellular fractions were
loaded with 1 to 10 µg protein, which was measured using the Bicinchoninic Acid Assay with
bovine serum albumin as the standard (Pierce, Rockford, IL). Commercially available mouse
monoclonal antibodies were used: βIII-tubulin (TUJ1; Covance; 1:1000), NR2B (clone N59/20;
NeuroMab; 1:1000), Ago2 (2E12-1C9; Novus Biologicals; 1:1000), Synaptophysin (SVP-38;
Sigma; 1:10,000). Commercially available rabbit polyclonal antibodies were also used:
BiP/GRP78 (Affinity BioReagents; 1:500), DARPP32 (2303; Cell Signaling Technology; 1:1000),
pan-Trk (MCTrks, SC-414; Santa Cruz Biotechnology; 1:250), E-cadherin (ab53033; Abcam;
1:1000) and Metadherin (Ab2989; Millipore; 1:500). Rabbit polyclonal antibody JH1159
(1:250)167 to the C-terminal 13 residues (amino acids 626-638) of rat PC2 was affinity-purified
using the antigenic peptide linked to AffiGel 15 beads (Bio-Rad Laboratories).
For quantitative analysis of purified PSDs from Saline and Cocaine treated mice, three
different amounts of sample were analyzed to verify the linearity of the response. After
transfer to polyvinylidene difluoride membranes (Millipore), blots were stained with
Coomassie Brilliant Blue R-250 and cut to separate the proteins of interest. Blots were
incubated in primary antibody overnight at 4°C, washed and incubated for 1h at room
temperature in the appropriate horseradish peroxidase-conjugated secondary antibody
(Pierce). Washed blots were incubated in Super Signal West Pico chemiluminescence substrate
(Pierce) for 5min and multiple exposures were collected using a Syngene imaging system
(Syngene, Frederick, MD). Signals were quantified using GeneTools software; for each dilution
of each PSD sample, the signal for each protein was normalized to βIII-tubulin and the
cocaine-to-saline ratio was determined.
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Statistical analyses
Data across qPCR assays were averaged because the values with respect to the
endogenous control for each miRNA were very consistent. Outliers were determined with the
GraphPad Grubbs’ test outlier calculator (graphpad.com/quickcalcs/Grubbs1.cfm). Differences
between saline and cocaine samples were evaluated using the 2-tailed Student's t-test with
unequal variances (NAc lysates) or equal variance (striatal-PSDs). For PSD Western blot
quantification, cocaine-to-saline ratios for the three amounts of each sample were averaged
and differences were evaluated using the 2-tailed Student's t-test with equal variance.
Pearson’s Coefficient represents the linear correlation coefficient between 2 samples, X and Y.
Pearson’s r = covariance(X,Y)/σXσy; σ, standard deviation.
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Abstract
Genetic association studies, pharmacological investigations, and analysis of mice
lacking individual genes have made it clear that cocaine administration and withdrawal have a
profound impact on multiple neurotransmitter systems. The GABAergic medium spiny
neurons of the nucleus accumbens (NAc) exhibit changes in the expression of genes encoding
receptors for glutamate and in the signaling pathways triggered by dopamine binding to Gprotein coupled dopamine receptors. Deep sequence analysis provides a sensitive,
quantitative and global analysis of the effects of cocaine on the NAc transcriptome. RNA
prepared from the NAc of adult male mice receiving daily injections of saline or cocaine, or
cocaine followed by a period of withdrawal, was used for high-throughput sequence analysis.
Changes were validated by qPCR or Western blot. Based on pathway analysis, a
preponderance of the genes affected by cocaine and withdrawal were involved in the
cadherin, heterotrimeric G-protein, and Wnt signaling pathways. Distinct subsets of cadherins
and protocadherins exhibited a sustained increase or decrease in expression. Sustained downregulation of several heterotrimeric G-protein β- and γ-subunits was observed. In addition to
altered expression of receptors for small molecule neurotransmitters, neuropeptides and
endocannabinoids, changes in the expression of plasma membrane transporters and vesicular
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neurotransmitter transporters were also observed. The effects of chronic cocaine and
withdrawal on the expression of genes essential to cholinergic, glutamatergic, GABAergic,
peptidergic, and endocannabinoid signaling are as profound as their effects on dopaminergic
transmission. Simultaneous targeting of multiple withdrawal-specific changes in gene
expression may facilitate development of new therapeutic approaches that are better able to
prevent relapse.

Introduction
Chronic drug exposure induces persistent changes in the brain that underlie the
addiction-associated behavioral abnormalities seen in human addicts and rodent models of
addiction. Data from broad expression studies using microarray technology and from singlegene approaches suggest that cocaine exposure elicits widespread modifications to the
transcriptional landscape, including drug-induced changes in epigenetics, RNA processing,
microRNAs, and gene transcription168,169. These alterations are believed to be integral to the
neural plasticity seen in addiction.
Dopaminergic, glutamatergic, and peptidergic signaling in the mesolimbic system are
altered in response to cocaine. Repeated exposure to cocaine leads to sensitization, the
progressive and persistent amplification of behavioral and motivational responses to a fixed
dose of the same drug95. Sensitization may persist for weeks to years after cessation of drug
taking, presumably contributing to a reformed addict’s risk for relapse170, which occurs in up to
ninety percent of addicted individuals171,172.
A majority of current research focuses on the effects of cocaine on the mesolimbic
dopaminergic system, identified in prior studies as the reward center of the brain83.
Dopaminergic projections from the ventral tegmental area as well as glutamatergic
projections from the prefrontal cortex synapse on inhibitory GABAergic medium spiny
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neurons in the ventral striatum (nucleus accumbens; NAc)87. This convergence of
dopaminergic and glutamatergic projections, as well as accompanying biochemical and
morphological changes, identified the NAc as a key integration point in the rewarding and
addictive effects of drugs of abuse86,95,170,171.
High-throughput sequencing has a low background signal, facilitates identification
and absolute quantification of low-abundance and novel transcripts3,5,6,8,9,169,173. We used nextgeneration sequencing of mRNAs purified from the NAc to obtain a more complete picture of
the molecular response to chronic cocaine exposure and withdrawal. Bioinformatic analysis of
cocaine-regulated transcripts revealed substantial involvement of the Wnt/cadherin and
heterotrimeric G-protein signaling pathways. Evaluation of the synthetic enzymes,
transporters, and receptors involved in catecholaminergic, glutamatergic, GABAergic,
cholinergic, and lipid signaling identified complex responses unique to cocaine and
withdrawal.

Results
Genome coverage
To characterize the effects of chronic cocaine and withdrawal on mRNA expression in
the NAc, we prepared mRNA-Seq libraries from RNA pooled from mice subjected to daily
saline injections (Saline), daily cocaine injections (Cocaine) or daily cocaine injections followed
by a week with no injections (Withdrawal). Paired-end sequencing yielded approximately 20
million uniquely mapped reads for each library (Table 3.1A). The current annotation of the
Mus musculus genome (2007, mm9) spans ~1.6 billion bases; 3.2% of the genome encodes
mature mRNAs and 40.6% encodes primary transcripts. We detected 5-6% of the genome in
the poly(A)+ RNA-Seq data from each NAc library. Approximately 80% of the reads in each
library mapped to annotated exons; 15-16% of reads mapped to introns and 5% of reads
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aligned to intergenic regions (Table 3.1B). Mitochondrial reads accounted for roughly 2% of all
mapped sequences in these libraries (Fig. 3.1). Scatter plots of mitochondrial (Fig. 3.2) and
ribosomal (Fig. 3.3) gene expression demonstrated no evidence for cocaine-regulation, so
subsequent analyses were performed on a filtered gene list that excluded both ribosomal and
mitochondrial genes.
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A. High-throughput sequencing alignment information
Sample
NAc lysate

Treatment

Number aligning reads

Total genome coverage

Saline

26,563,428

3.8%

Cocaine

24,696,981

3.8%

Withdrawal

19,767,382

3.1%

B. Read mapping
Sample
NAc lysate

Treatment

Exonic

Intronic

Intergenic

Saline

79.4%

13.5%

3.1%

Cocaine

79.0%

16.1%

4.9%

Withdrawal

79.0%

16.2%

4.8%

Table 3.1 Read mapping and base coverage for RNA-Seq data
Sequences from NAc libraries were aligned to the Mus musculus reference genome (2007, mm9; NCBI
Build 37) using Bowtie24 and allowing up to 2-mismatches. (A) Aligning read numbers and percent
coverage of the genome. (B) Reads were characterized as aligning to exonic, intronic, or intergenic
regions based on the existing annotation.
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Figure 3.1 Contribution of reads mapping to mitochondrial chromosome
The proportion of mapped sequence reads from NAc lysate libraries aligning to the mitochondrial
chromosome was determined. Abbreviations: Sal, Saline; Coc, Cocaine; W/D, Withdrawal; chrM,
mitochondrial chromosome.
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Figure 3.2 High-throughput sequence analysis of mitochondrial NAc mRNAs
Pairwise scatter plots of mRNA expression data for NAc lysate (A-C) libraries (Saline, Cocaine, and
Withdrawal) prepared from adult mouse; shown as log10(RPKM) per sample. Scatter plots include only
mitochondrial genes (from GO:0005840). R2 values were calculated by least squares best fit.
Abbreviation: RPKM, reads per kilobase gene model per million mapped reads5.
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Figure 3.3 High-throughput sequence analysis of ribosomal NAc mRNAs
Pairwise scatter plots of mRNA expression data for NAc lysate (A-C) libraries (Saline, Cocaine, and
Withdrawal) prepared from adult mouse; shown as log10(RPKM) per sample. Scatter plots only include
ribosomal genes (from GO:0005739). R2 values were calculated by least squares best fit. Abbreviation:
RPKM, reads per kilobase gene model per million mapped reads5.
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Genome-wide assessment of the effect of cocaine on gene expression
Gene expression over a broad (106) dynamic range was evaluated in each library.
Expression was quantified in reads per kilobase of exon per million mapped sequence reads
(RPKM), a normalized measure of exonic read density5. For the three NAc libraries, pairwise
scatter plots revealed similarly varied expression between the Saline/Cocaine,
Saline/Withdrawal and Cocaine/Withdrawal libraries (Fig. 3.4A-C). The variability of gene
expression between samples was highest for genes expressed at lower levels. For this reason,
a lower limit of expression was applied before examining regulation. Since biogenic amine
transporter (Slc6a2, NET; Slc6a3, DAT; Slc6a4, SERT) transcripts are not expressed in the NAc
(http://mouse.brain-map.org/), we used their RPKM values to set this lower limit; for inclusion
in subsequent analyses, a gene had to have an RPKM of > 1.0 in at least one of the three
treatment groups. We used qPCR to validate the RNA-Seq data (Fig. 3.4D,E). The RNA-Seq and
qPCR expression levels of 47 transcripts from five neurotransmitter systems from the Saline
sample showed strong agreement across the two methods (Pearson’s r = 0.75) over a greater
than 1000-fold range of expression (Fig. 3.4D). A comparison of the ratios of Cocaine/Saline
measured by RNA-Seq and qPCR was also carried out (Fig. 3.4E). Cocaine-mediated changes in
gene expression estimated from the RNA-Seq data were consistently larger than the changes
observed with qPCR; nevertheless, the ratios show good qualitative agreement (Pearson’s r =
0.60). Differences presumably reflect the much larger dynamic range of RNA-Seq and
quantification across entire transcripts rather than between single primer pairs.

Regulation of NAc transcript levels by cocaine and withdrawal
To evaluate enrichment and depletion of transcripts in NAc lysates prepared from
mice in the Saline, Cocaine, and Withdrawal groups, we calculated the relative abundance of
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Figure 3.4 High-throughput sequence analysis of NAc mRNA
(A-C) Pairwise scatter plots of mRNA expression data for NAc libraries; shown as log10(RPKM) per sample.
Ribosomal and mitochondrial genes are not included in the scatter plots. R2 values were calculated by
least squares best fit. Abbreviations: Sal, Saline; Coc, Cocaine; W/D, Withdrawal; RPKM, reads per
kilobase gene model per million mapped reads5. (D) RPKM data for 47 transcripts in the Saline library are
compared to qPCR data (normalized to Glyceraldehyde 3-phosphate dehydrogenase, GAPDH) for the
same transcripts; Pearson’s Coefficient represents the linear correlation coefficient, r. (E) Cocaine/Saline
ratios for the same 47 transcripts were calculated using RPKM data and qPCR data. Pearson’s Coefficient
represents the linear correlation coefficient, r, between two samples, X and Y. Pearson’s r =
covariance(X,Y)/σXσY, where σ is the standard deviation.
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each mRNA in the three treatment groups, computed Z-scores across samples, and
hierarchically clustered genes for visualization in a heat map. Of the 19,890 detected genes,
13,184 were expressed in at least one library at an RPKM > 1.0 and were used in downstream
analyses. Several patterns of expression emerged from hierarchical clustering, including
transcripts showing (i) sustained increases in both Cocaine and Withdrawal, (ii) increases only
in Withdrawal, (iii) transient increases only in Cocaine, (iv) transient decreases only in Cocaine,
and (v) sustained decreases in Cocaine and Withdrawal (Fig. 3.5A). The full gene list for each
cluster is available in Table 3.S2.
Since transcripts exhibiting a sustained change in response to cocaine are included in
Clusters i (sustained increase), ii (increase, Withdrawal), and v (sustained decrease), we used
Panther Pathway (Table 3.2A and Table 3.S3) analysis to identify common pathways. Three
pathways were enriched (P < 0.005) in these three Clusters: cadherin signaling, heterotrimeric
G-protein signaling (Gαi and Gαs-mediated), and Wnt signaling; since there was a great deal of
overlap in the cadherin and Wnt signaling pathways, they are discussed together. Other
pathways were unique to specific clusters (Table 3.S3). For example, components of the
ionotropic glutamate receptor, metabotropic glutamate receptor group III, and nicotinic
acetylcholine receptor pathways were enriched only in Cluster i (sustained increase) while
components of the muscarinic acetylcholine receptor 1 and 3 pathway were enriched in
Cluster ii (increase, Withdrawal).
The pathways exhibiting sustained changes were examined in more detail. Unique
sets of cadherins and protocadherins appeared in each Cluster (Table 3.3). While many
cadherins and protocadherins showed a sustained increase in expression (Cluster i), others
increased only in Withdrawal (Cluster ii) or showed a transient response to Cocaine (Clusters iii
and iv). The clustered families of protocadherins, Pcdhα, -β, and γ, are important in neuronal
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Figure 3.5 Differential regulation of clusters of genes in the NAc following cocaine and
withdrawal
(A) Normalized mRNA frequency as a function of total reads for NAc lysate libraries (Saline, Cocaine,
Withdrawal) was calculated for all genes in which one sample had an RPKM ≥ 1.0 (n = 13,184).
Hierarchical gene expression clustering using Gene Cluster 3.0 and Java TreeView generated the
dendrogram and heat map. Z-score was computed on normalized mRNA frequency across all samples.
Blue, low expression; yellow, high expression; grey, no expression. Gene lists from the indicated Clusters
(i-v) were used in subsequent protein class and pathway analyses. (B) The effects of Cocaine on one of
the protocadherins identified as a target were verified. Subcellular fractionation of striatal tissue
revealed enrichment of PCDH10 at the PSD. PSDs purified from the striata of Saline and Cocaine treated
mice were analyzed for PCDH10; after normalization to bIII tubulin, the Coc/Sal ratio for PCDH10 rose
24% (P < 0.01; t-test).

Mus
musculus
genes
(26,185)

(i) Sustained
Increase, Coc &
W/D (1,387)

(i) Pvalue

(ii) Increase,
W/D only
(1,001)

(ii) Pvalue

(v) Sustained
Decrease, Coc
& W/D (2,670)

(v) Pvalue

Cadherin signaling

167

19

1.94E-03

16

9.25E-04

30

2.70E-03

Heterotrimeric G-protein
signaling – Gαi & Gαs

169

19

2.21E-03

18

1.32E-04

32

8.89E-04

Wnt signaling

348

46

3.67E-08

27

5.77E-04

64

9.02E-06

PANTHER Pathway

Table 3.2 Panther Pathways from Cocaine- and Withdrawal-regulated genes in the NAc
Gene lists from Clusters i-v (Fig. 3.5A) were used in Panther Pathway and Protein Class analysis (http://www.pantherdb.org); pathways
enriched (P < 0.005) in all three lists relative to the Mus musculus reference genome are indicated. Complete pathway lists are provided in
Table 3.S3. Abbreviations: Coc, Cocaine; W/D, Withdrawal.
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development and are synaptically enriched in mature myelinated neurons174. The Pcdhb gene
cluster includes 22 genes; three showed a sustained increase (Cluster i), five were increased
only after Withdrawal (Cluster ii), five exhibited an increase only after Cocaine (Cluster iii), and
one showed a sustained decrease in expression (Cluster v). In contrast, the Pcdhg cluster of 23
genes exhibited a more homogeneous expression pattern in which expression of all 21
detected isoforms showed a sustained decrease (Cluster v).
We used an antibody to protocadherin 10 (PCDH10), which is known to play a role in
the development of striatal axons and thalamocortical projections175, to evaluate its
subcellular localization and quantify its levels in postsynaptic densities (PSDs) purified from
the striata of saline- and cocaine-treated mice. PCDH10 was enriched in PSD preparations (Fig.
3.5B); furthermore, PSDs purified from striatal extracts of cocaine-treated mice contained
more PCDH10 than striatal PSDs from saline controls. A role for extracellular matrix proteins,
including cadherins and protocadherins, is consistent with previous studies of cocaineregulated gene expression in mice169 and postmortem human brain112,176.
Consistent with the literature, heterotrimeric G-protein signaling (Gαi and Gαsmediated) was identified as a major pathway targeted by cocaine. In addition to G-protein
coupled receptors (GPCRs) for the major neurotransmitters (discussed below), neuropeptide
(opioid, galanin, somatostatin), lipid, and cadherin-type GPCRs showed cocaine-related
changes in expression (Table 3.3).
Panther Pathway analysis identified cocaine-regulated changes in the repertoire of
intracellular signaling proteins downstream of the regulated Gαi and Gαs-coupled GPCRs
(Table 3.3 and Fig. 3.6). The diagram in Fig. 3.6 depicts the complex interplay of intracellular
signaling proteins. For example, only two members of the Mus arrestin gene family are
expressed outside of the retina177; Arrb1 showed a sustained increase in expression (Cluster i)
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Model based on Panther Pathway diagram (http://www.pantherdb.org). Venn diagram depicts color key for signaling components. Genes labeled yellow
showed a sustained increase in Coc and W/D (cluster i), red genes increased in W/D only (cluster ii), and blue genes had decreased expression in both Coc
and W/D (cluster v); overlap colors indicate contribution of > 1 cluster to signaling group. For example, GPCRs, which appear in all three clusters, are shown
in magenta. Genes from Clusters i, ii, and v were used for this analysis. Abbreviations: Coc, Cocaine; W/D, Withdrawal.

71

(i) Sustained Increase,
Coc & W/D

(ii) Increase, W/D only

(iii) Transient Increase,
Coc only

(iv) Transient Decrease,
Coc only

Cdh4, Cdh5, Cdh6, Cdh8, Cdh11

Cdh7, Cdh19, Cdh22

Cdh24

Cdh13

(v) Sustained Decrease,
Coc & W/D

Cadherin / Wnt Signaling
Cadherins

Protocadherins

Pcdh1, Pcdh10, Pcdh18, Pcdhb13,
Pcdhb14, Pcdhb16

Pcdhb2, Pcdhb6, Pcdhb7, Pcdhb8,
Pcdhb9

Pcdh20, Pcdhb5, Pcdhb10,
Pcdhb11, Pcdhb19, Pcdhb20

Fzd6, Fzd7, Mc3r, Oprd1, Pth1r,
Smo, Trhr2

Hcrtr1, Npbwr1, Npy2r, Oxtr, Sstr3,
Tacr3

Pcdha4, Pcdhb12, Pcdhga1,
Pcdhga2, Pcdhga3, Pcdhga4,
Pcdhga5, Pcdhga6, Pcdhga7,
Pcdhga8, Pcdhga9, Pcdhga10,
Pcdhga11, Pcdhga12, Pcdhgb1,
Pcdhgb2, Pcdhgb4, Pcdhgb5,
Pcdhgb6, Pcdhgb7, Pcdhgb8,
Pcdhgc3, Pcdhgc4, Pcdhgc5

Heterotrimeric G-Protein Signaling (Gαi & Gαs)
Type of GPCR:
Neuropeptide binding

Fzd5, Fzd8, Hcrtr2, Npffr1, Oprk1,
Oprm1, Prlhr, Tacr1

Lipid binding

S1pr3

Cadherin type

Celsr2, Celsr3

Fzd9, Gipr, Nmbr, Npy5r

Mc4r, Mchr1, Mtnr1a, Sstr2

S1pr4

Lpar1

Grk6

Grk1

Celsr1

Intracellular signaling proteins:
GPCR kinases
Arrestins

Arrb1

Arrb2

Gβ subunits

Gnb4

Gγ subunits

Gng7

Gng2

Rgs6

Rgs8, Rgs11

Rgs17

Adcy1, Adcy4, Adcy6, Adcy9

Adcy2, Adcy5

Adcy8

RGSs
Adenylate cyclases
Phosphorylase b kinases
CREBs

Gnb1, Gnb1l, Gnb2, Gnb2l1, Gnb5
Gng3, Gng8, Gng10, Gng11, Gng13
Rgs9, Rgs19

Rgs2, Rgs4, Rgs10, Rgs16, Rgs20

Phka2

Phkg1, Phkg2

Creb3l2, Crebbp

Creb3

Table 3.3 Clustered genes from the Cadherin/Wnt and Heterotrimeric G-Protein Signaling Pathways
The cadherin and protocadherin genes appearing in Clusters i-v are identified. Genes in the heterotrimeric G-protein signaling pathway (Gαi and Gαs) that
fell into Clusters i-v are grouped by function; GPCRs for dopamine, GABA, glutamate and acetylcholine are discussed separately and GPCRs without known
ligands are not listed. Intracellular signaling proteins are grouped by function. Abbreviations: Coc, Cocaine; W/D, Withdrawal.
72

73

while Arrb2 exhibited a sustained decrease (Cluster v). Transcripts encoding the β- and γsubunits of heterotrimeric G-proteins were primarily identified in Cluster v (sustained
decrease). In contrast, Regulators of G-protein signaling (RGS genes) appeared in all clusters.
Transcripts encoding four adenylate cyclase genes showed a sustained increase in expression
(Cluster i) while the transcripts encoding two additional adenylate cyclase genes
demonstrated increased expression only in the Withdrawal group (Cluster ii).
Panther Protein Class analysis (Table 3.S4) identified Cytoskeletal Proteins,
Transcription Factors, and Transferases as the three Protein Classes enriched in genes
exhibiting a sustained response (Clusters i, ii, and v; P < 0.0001). Sustained up-regulation of Gprotein modulators and guanyl-nucleotide exchange factors (Cluster i) was also observed.
Several Protein Classes involved in interactions with Ca2+ (calcium-binding proteins,
calmodulin and intracellular calcium-sensing proteins) were enriched only in Cluster v
(sustained down-regulation). GPCRs, ligand-gated ion channels, membrane trafficking
proteins and neuropeptides were also enriched in Cluster v.

Widespread effects of cocaine and withdrawal on catecholaminergic, GABAergic,
cholinergic, glutamatergic, and endocannabinoid pathways
Dopamine, norepinephrine, and serotonin receptors expressed in the NAc play a
critical role in addiction. Transcripts encoding the dopamine receptors, Drd1a, Drd2, Drd3, and
Drd5, exhibited different patterns of response to cocaine and withdrawal (Fig. 3.7). Drd1a was
known to decrease in response to cocaine treatment, while Drd2 was known to increase178.
Adra1a, Adra2a and Adrb1 adrenergic receptor expression rose in response to cocaine
treatment, while expression of Adra1b, Adra2b, and Adra2c fell. Six of the twelve serotonin
receptors (Htr1b, Htr2a, Htr2c, Htr4, Htr5a, Htr6) exhibited increased expression in response to
cocaine and/or withdrawal. The long-term changes during withdrawal were verified by qPCR
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Figure 3.7 Regulation of Receptors for Biogenic Amines
RPKM data are shown for dopamine, adrenergic and serotonin receptor transcripts (RPKM > 1) in the
Saline library. Z-scores were calculated as described in Methods. Transcripts included in this group but
expressed at an RPKM < 1 are listed to the side. Ppp1r1b (DARPP32), a multiply phosphorylated
phosphatase inhibitor highly expressed in medium spiny neurons, is included for comparison.
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for Drd1a, Drd2, Adra1a, Adra2b, Htr1d, Htr2a, Htr2c, and Ppp1r1b (DARPP32).
Over 90% of the neurons in the NAc are GABAergic medium spiny interneurons179; the
genes involved in synthesizing, storing and retrieving GABA (γ-aminobutyric acid) are
expressed in the NAc, along with ionotropic and metabotropic GABA receptors (Fig. 3.8).
Expression of the GABA-synthesizing enzymes (Gad65, Gad67), the vesicular inhibitory amino
acid transmitter transporter (Viatt) and the plasma membrane transporters (Gat1, Gat3 and
Gat4) rose in response to cocaine and withdrawal. The three Na+/Cl--dependent GABA
transporters are expressed by astrocytes and retrieve GABA after secretion180-182; neurons also
express Gat1183. Levels of Gat4 were highest after Cocaine while levels of Gat1 were highest in
Withdrawal. Multiple GABAA receptor subunits are expressed at similar levels; while some
showed a sustained increase in expression (Gabrb2, Gabrb3, Gabrg3, Gabrq), Gabrb1 expression
decreased in Withdrawal and Gabrd expression decreased after Cocaine but recovered in
Withdrawal. Expression of GABAB receptor subunits (Gabbr1, Gabbr2) increased after Cocaine
and increased further during Withdrawal.
Glutamatergic signaling plays an essential role in drug abuse, with major
glutamatergic inputs onto NAc medium spiny neurons (MSNs) coming from amygdala,
hippocampus, and prefrontal cortex184,185. The effects of cocaine on expression of ionotropic
and metabotropic glutamate receptors have been studied in detail171,184,186 and were largely
confirmed in our analysis (Fig. 3.9). Glutamatergic inputs acutely excite NAc MSNs primarily via
activation of AMPA receptors, a step considered necessary for initiation of drug seeking
behavior187. AMPA receptor expression showed only small changes during Cocaine
administration; Gria1 increased substantially while Gria3 decreased during Withdrawal
(confirmed by qPCR). Expression of several NMDA receptor subunits increased during Cocaine
administration (Grin1, Grin2a, Grin2b, Grin2d, Grin3a) (several confirmed by qPCR). Expression
of kainate receptors Grik1, Grik2, and Grik3 showed a sustained increase while expression of
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Figure 3.8 Regulation of Genes Affecting GABAergic Transmission
Data were analyzed as described for Fig. 3.7. The transcripts encoding glutamic acid decarboxylase 65
and 67 (Gad1 and Gad2) are expressed at similar levels. GABA transport into synaptic vesicles requires
Slc36a1; retrieval of GABA from extracellular space requires Slc6a1, Slc6a13, or Slca11. Multiple
ionotropic GABAA receptor subunits are expressed in the NAc; expression of metabotropic GABAB
receptor Gabbr1 greatly exceeds expression of Gabbr2.
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Figure 3.9 Regulation of Genes Affecting Glutamatergic Transmission
Data were analyzed as described for Fig. 3.7. Expression of all three vesicular glutamate transporters
(Vglut) and four of the plasma membrane glutamate transporters (Slc1a1, Slc1a2, Slc1a3, Slc1a6) was
above the cutoff level. Multiple subunits of the ionotropic glutamate receptors (AMPA, NMDA, and
Kainate) and multiple metabotropic glutamate receptors are expressed at similar levels.
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Grik4 and Grik5 showed a sustained decrease. Expression of the five most-highly expressed
metabotropic receptors for glutamate (Grm1, Grm3, Grm4, Grm5, and Grm7) showed a
sustained increase. Vesicular glutamate transporters (Vglut) can be expressed in GABAergic
and cholinergic neurons as well as in glial cells188. Transcripts encoding all three Vgluts were
detectable in the NAc, which contains no primarily glutamatergic neurons; expression of
Vglut1 mRNA exceeded that of Vglut2. Na+-dependent plasma membrane glutamate
transporters (Eaat1 through Eaat5), which remove glutamate from the synaptic cleft and
perisynaptic area, also play a critical role in glutamatergic transmission. Three of the four Eaats
expressed in the NAc (Eaat1, Eaat2, and Eaat3) exhibited a sustained increase in expression
while Eaat4 exhibited reduced expression in Withdrawal. Eaat1 and Eaat2 are primarily
expressed in glia, while Eaat3, Eaat4 and Eaat5 show widespread neuronal expression
throughout the brain189.
A small population of giant aspiny cholinergic interneurons is found in the NAc190;
expression of both the plasma membrane choline transporter (Cht1), which provides the ratelimiting substrate, and choline acetyltransferase (ChAT) was increased by Cocaine and further
increased by Withdrawal (Fig. 3.10). Expression of each of the major nicotinic ACh receptor
subunits found in the NAc (Chrna4, Chrna7, and Chrnb2) and three muscarinic ACh receptors
(Chrm2, Chrm3, and Chrm5) showed sustained increases, many verified by qPCR.
The endocannabinoid system is heavily involved in many reward-seeking responses to
drugs of abuse191. Levels of transcripts encoding Cnr1 (the CB1 endocannabinoid receptor) and
the cannabinoid synthetic enzymes Dagla and Napepld showed sustained increases in Cocaine
and Withdrawal, while Daglb showed a sustained decrease (Fig. 3.11). The effect of Cocaine
expression on each of these genes was confirmed by qPCR analysis of two separate sets of
animals.
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Figure 3.10 Regulation of Genes Affecting Cholinergic Transmission
Data were analyzed as described for Fig. 3.7. Although only a small percentage of the neurons in the
NAc are cholinergic, choline acetyltransferase (ChAT), high affinity plasma membrane choline
transporter (Slc5a7) and vesicular acetylcholine transporter (Slc18a3) transcript levels all fall above the 1
RPKM cutoff. Only three of the many nicotinic acetylcholine receptor subunits are expressed in the NAc
while all five muscarinic receptors are expressed. Expression of each of the genes involved in cholinergic
transmission is elevated in withdrawal.
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Figure 3.11 Regulation of Genes Affecting Endocannabinoid Signaling
RPKM data were analyzed as described for Fig. 3.7. While transcripts encoding the two
enzymes that synthesize the endocannabinoid 2-arachidonoylglycerol (diacylglycerol lipase α
and β; Dagla and Daglb) are expressed at similar levels in the NAc, they respond to cocaine in
an opposite manner. Expression of transcripts encoding cannabinoid receptor 1 (Cnr1) greatly
exceeds that of cannabinoid receptor 2 (Cnr2) and is responsive to cocaine.
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Discussion
Single-gene, proteomic, and microarray analyses demonstrated that cocaine produces
widespread, multi-faceted responses in the NAc168,169. Next-generation sequencing identified
pathways not previously thought to play any role in addiction and facilitated systematic
cataloging of changes in all components of known signaling pathways. With greater
sequencing depth, changes in editing, splicing, imprinting and allele-specific expression can
be quantified3,5,6,8,9,169,173. Components of the Wnt, cadherin, and heterotrimeric G-protein
signaling pathways were over-represented among cocaine-responsive transcripts; cross-talk
between these signaling cascades is extensive192.

Global comparisons of gene expression identify signaling pathways targeted by
cocaine
Cadherin/Wnt pathways
By sequencing PSD-localized, cocaine-regulated striatal microRNAs, we previously
identified miR-8 family members as key players in the response to cocaine169. Although the
miR-8 family has primarily been studied for its role in cancer progression and metastasis, we
verified cocaine regulation of two bioinformatically-predicted cadherin family targets169. We
identified over forty cocaine-regulated cadherin and protocadherin transcripts; genes from
the Pcdhβ cluster were primarily up-regulated following cocaine in both a transient and
sustained fashion (Clusters i-iii), whereas genes from the Pcdhγ cluster were exclusively found
to undergo a sustained down-regulation following cocaine exposure (Cluster v).
A few studies have suggested a role for cell adhesion and extracellular matrix proteins
in the response to cocaine. Disturbances in cortical cytoarchitecture in animal models of
prenatal cocaine exposure resembled changes observed when Wnt/cadherin pathway
function was altered; this lead to the prediction that these pathways play a role in the
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response to cocaine193. As observed here (Cluster i), Cdh6 and Cdh11 expression increased in
the frontal cortex of E18 pups taken from dams treated with cocaine for 10 days193. Also
contributing to alterations in the extracellular milieu is cocaine-mediated down-regulation of
glycosyltransferase expression; these enzymes are crucial for the synthesis of cell surface
glycoproteins. In a compilation documenting changes in gene expression in postmortem
tissue from cocaine addicts, cell adhesion molecules were identified as major targets109,112.

Heterotrimeric G-protein pathways
Transcripts encoding GPCRs, heterotrimeric G-protein subunits, regulators of Gprotein signaling (RGS), GPCR kinases (GRK) and adenylate cyclases (Adcy) responded
differently to cocaine and withdrawal. Genes encoding GPCRs and RGSs were identified in all
five clusters. Particularly striking was the prevalence of GPCRs for neuropeptides, with
different receptor subtypes in different clusters (e.g., Wnt, galanin, somatostatin, and opioid
receptors). The µ-opioid (Oprm1) receptor, associated with increased sensations of reward and
pleasure, showed a sustained increase in expression in response to cocaine, as expected104,172,
as did the endocannabinoid (Cnr1) receptor194,195. The δ-opioid receptor (Oprd1), also involved
in positive reinforcement of drugs of abuse196, increased expression only in Withdrawal. The κopioid receptor (Oprk1), crucial to the negative emotional state of withdrawal172, showed a
sustained increase, as also observed in postmortem tissue from cocaine overdose victims197.
Transcripts encoding several neuropeptides were substantially down-regulated by cocaine:
Pomc (proopiomelanocortin), Tac1 (tachykinin), Oxt (oxytocin) and Cartpt (CART; cocaine and
amphetamine regulated peptide).
Consistent with a major role for cadherins in the response to cocaine, seven
transmembrane cadherins (Celsr) were identified in clusters i and ii. Genes encoding adenylate
cyclases appeared in Clusters i, ii, and iii. On the other hand, the majority of genes encoding
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the β- and γ-subunits of the heterotrimeric G-proteins fell into cluster v (sustained decrease).
The few genes whose expression is uniquely regulated in Withdrawal are of special interest;
these transcripts may provide insight into the biochemical and cell biological alterations
underlying reinstatement of drug-seeking behavior, ultimately helping identify potential
therapeutic approaches to prevent relapse185.

Neurotransmitter-specific effects
Expression of the D3 dopamine receptor (Drd3) increased in response to Cocaine and
remained elevated after Withdrawal (cluster i); in contrast, D2 dopamine receptor (Drd2)
expression increased only after Withdrawal. An increase in D3 receptor expression was
observed in the NAc of cocaine overdose victims197 and in rats 45 days after cocaine selfadministration ceased157. Recent work suggests that dopamine receptor dysregulation,
mediated by decreased D2 and increased D3 receptor expression, contributes to increased
cocaine-seeking behavior after prolonged withdrawal157. Alterations in serotonin signaling are
also recognized as important in drug addiction198, and we observed cocaine-responsive
changes in gene expression across many of the serotonin receptors.
Expression of many of the genes responsible for GABA synthesis, transport into
synaptic vesicles, and retrieval from the synaptic cleft rose following cocaine treatment and
increased further during withdrawal. Daily cocaine injections decreased GABAA receptormediated maximal evoked currents and miniature inhibitory postsynaptic currents on
dopamine neurons in the VTA199; furthermore, GABAA receptor function has been implicated in
dopamine-mediated alcohol reward200. GABAB receptor agonists attenuated cocaine
reinforcement and reduced cocaine craving in a study of human cocaine users201; while the
precise mechanism of these behavioral effects is unknown, activation of GABAB receptors in
the NAc reduces dopamine release from dopaminergic projections from the VTA202. Changes
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in GABAA receptor subunit expression, which fell during withdrawal, and in GABAB receptor
expression, which rose, could contribute significantly to altered synaptic transmission.
A growing body of literature has focused on the role of AMPA, NMDA and kainate
receptor-mediated glutamatergic transmission into the NAc in the development of addiction
and addictive-like behaviors186. Increased glutamate receptor mRNA expression parallels
increases in cell surface expression of GluR1-containing AMPA receptors following cocaine
withdrawal203, along with a specific population of GluR2-lacking calcium-permeable AMPA
receptors185. We saw sustained up-regulation of Gria1 (GluR1) transcripts, a transient increase
in Gria4 (GluR4) transcripts, and no change in Gria2 (GluR2) transcripts. While expression of
kainate receptor 3 (Grik3) rose substantially, expression of Grik4 and Grik5 fell. NMDA receptors
are critical for the behavioral response to drugs of abuse204,205; new spines appearing in the
NAc following cocaine are enriched in NMDA receptors and are not formed if NMDA receptor
currents are blocked206,207. Correspondingly, transcripts encoding several NMDA receptor
subunits rose in response to cocaine. Expression of the more prevalent metabotropic
glutamate receptors also increased. Perhaps the most significant finding is that expression of
Slc17a7 and Slc17a6 (Vglut1 and Vglut2) exhibited sustained down-regulation after cocaine
treatment and withdrawal.
Cholinergic transmission in the NAc contributes to addiction through the modulation
of dopamine signaling and reward processing208. Increased expression of both choline
acetyltransferase and the plasma membrane choline transporter in the giant aspiny
cholinergic interneurons could increase cholinergic signaling at both nicotinic and muscarinic
ACh receptors expressed on the GABAergic output neurons.
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Conclusion
We used next-generation sequencing to generate a comprehensive catalog of
transcriptional changes that occur in response to cocaine treatment and withdrawal in the
primary reward center of the brain. Pathway analysis enabled the complete categorization of
transcriptional changes in signaling pathways known to be important in addiction along with
the identification of pathways not previously considered important. These data should serve
as a resource for development of new targets for cocaine therapy and facilitate selection of
protein interaction and pathway targets for future study. With more information about their
normal physiological roles, the extracellular domains of the many cadherins and
protocadherins that respond to cocaine may be useful therapeutic targets. Pharmaceutical
cocktails targeted to a subset of the specific GPCRs whose expression is altered during
withdrawal may prove to be more effective than treatments targeting a single pathway.

Methods and Materials
Cocaine Treatment of Mice
Adult male C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine; 2-5 months old)
were group-housed in the animal facility at the University of Connecticut Health Center on a
12 h light/dark cycle (lights, 7:00am-7:00pm) and handled in accordance with Institutional
Animal Care and Use Committee guidelines. After acclimation for one week, animals were
handled for 1 min/day for 2-3 days prior to injections. On each treatment day, animals were
allowed to acclimate to the behavior room for 45-60 minutes before beginning injections.
Cocaine treatment was performed as described169. Animals were given saline (10
ml/kg/day) or cocaine (10 or 20 mg/kg/day) intraperitoneally for 7 days and locomotor activity
was monitored daily using a 15” x 15” Plexiglas chamber (PAS Open Field System, San Diego
Instruments); after the 7th injection, locomotor activity was three-fold higher in mice receiving
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cocaine than in mice receiving saline (Fig. 3.12)98,209. Administering 10 mg/kg cocaine on the
first and last days produces more reliable locomotor sensitization (locomotor ambulations on
day 7 ÷ day 1), as originally demonstrated in rats166, and was used in later experimental sets in
this work. Animals were sacrificed by decapitation 24 hours after the final injection with the
exception of mice in the withdrawal groups, which were kept in the home cage for 8 or 28
days after the final cocaine dose prior to tissue harvest; elevated locomotor responding was
maintained for the 28 day withdrawal period (Fig. 3.12). Quantitative polymerase chain
reaction (qPCR) validation was performed on RNA samples used for library preparation (8
animals analyzed separately in each treatment group) and on two biological replicate groups
of mice sensitized in a similar manner98: 8 each saline and cocaine; 4 each saline, cocaine, and
28 days withdrawal. Pairwise comparisons were performed and subjected to t-test (p<0.05
taken as significant).

RNA and Library Preparation and Sequencing
NAc punches were taken from individual mice (at least 8 animals/treatment group).
Total RNA was prepared using TRIzol (Invitrogen)169. Average yield of total RNA per NAc punch
was 6.3±0.6 mg. Total RNA used for NAc library preparation consisted of equal amounts of
RNA from 8 individual mice for each treatment. One Saline, one Cocaine, and one 7-day
Withdrawal mRNA-Seq library was prepared from each pooled RNA sample according to
manufacturer’s specifications (Illumina). Briefly, total RNA was treated with DNase I; poly(A)+
RNA purified using Dynal magnetic beads (Invitrogen) was fragmented by partial alkaline
hydrolysis (Ambion) and reverse-transcribed using random primers and SuperScript II
(Invitrogen). cDNA was size-selected (∼200 bp insert) on 2% agarose gels. Libraries were
prepared for sequencing using the Paired-End DNA Sample Prep Kit (Illumina).
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Figure 3.12 Cocaine causes long-lasting locomotor sensitization
(A) Two sets of 8 male mice were subjected to saline or cocaine injection as indicated, and locomotor
activity for the subsequent 45 min was recorded. RNA from these mice was used for Q-PCR validation.
(B) Two sets of 8 male mice were subjected to saline or 20 mg/kg cocaine injection for 8 days followed
by 30 min of locomotor monitoring. A third set of 8 male mice received 20 mg/kg cocaine for 8 days,
was subjected to withdrawal for 8 days, and then locomotion was monitored in 3 of the 8 mice
following a test injection of 20 mg/kg cocaine. RNA from these mice was used for RNA-Seq. (C) An
additional two sets of 4 male mice each were subjected to saline or 20 mg/kg cocaine injection daily for
7 days, followed by 15 min of locomotor monitoring; a third set of 4 mice received cocaine for 7 days,
was subjected to withdrawal for 28 days, and then locomotion was monitored after a test injection of 20
mg/kg cocaine. RNA from these mice was used for Q-PCR validation. Abbreviations: Sal, Saline; Coc,
Cocaine; W/D, Withdrawal. The number following the abbreviation indicated number of days in a given
treatment paradigm.
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NAc libraries were sequenced in nine lanes (3 technical replicates per sample) on an
Illumina GAIIx using a 37-cycle paired-end sequencing protocol. Replicates were analyzed for
intra-sample disparity and read data from all three lanes were then merged into one
composite data file per sample; intra-sample coefficient of determination, R2 ≥ 0.98. The
composite file was used for subsequent analyses.

mRNA-Seq Data Analysis
Sequences and quality scores were extracted from image files using Firecrest, Bustard,
and GERALD software. Sequences were aligned to the Mus musculus genome (2007, mm9;
NCBI Build 37) using Bowtie (http://bowtie-bio.sourceforge.net; version 0.12.7)24 permitting
multi-alignment and allowing up to 2-mismatches. Ambiguous alignments were resolved
using the Spliced Paired-end Aligner Perl script210. Robust assembly of novel transcripts and a
complete analysis of cocaine-induced alternative splicing requires greater transcript coverage
and read depth than we obtained25.
Normalized mRNA expression was calculated as RPKM (reads per kilobase gene model
per million mapped reads)5 from aligned sequence reads; Z-scores were computed from
frequency data using the following equation: (x - µ)/σ; x, sample frequency; µ, mean across all
samples; σ, standard deviation across all samples. Gene expression data (Z-scores) were
hierarchically clustered using Gene Cluster 3.0 (http://rana.lbl.gov/EisenSoftware.htm); heat
maps were generated using Java Treeview
(http://www.sourceforge.net/projects/jtreeview/files). Gene lists were submitted to the
Panther website (http://www.pantherdb.org) for analysis of Pathway and Protein Class
enrichment compared to the Mus musculus reference gene list. Western and qPCR analyses
were performed as described169; primer sequences are in Table 3.5.
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Table 3.4 Primers used for quantitative PCR

Gene Name
GAPDH (G3PDH) NM_008084.2
glutamate receptor, ionotropic, AMPA4
glutamate receptor, ionotropic, AMPA3 (alpha 3)
glutamate receptor, ionotropic, NMDA2B
dopamine receptor D1A
dopamine receptor 2

glutamate receptor, ionotropic, AMPA1

mNR2A
mDARPP32
GAD65
GAD67
GABA-a1 Gabar1
DGL-alpha
DGL-beta
NAPE-PLD
Choline acetyltransferase
M1 muscarinic R
B2 Nicotinic R
GABA-B1
EAAT1 glial
EAAT2 glial
EAAT3 neuronal
EAAT4 neuronal
GABA-B1
GABA transporter

Sequence
TTGTCAGCAATGCATCCTGCACCACC	
  
CTGAGTGGCAGTGATGGCATGGAC	
  
CCCAGTATTCTAGAGGGGTGTTTGCC	
  
CTTCAGTGGGGAAGCTTGGTGTGATG	
  
CACACGACGCAATACTGGTCATAGCAG	
  
GACTCCAGGGCACAGCAGGATTTG	
  
CTGAGACTGAAGAACAGGAAGATGACCATC	
  
CGGGACTGTATTCCGCATGCAGG	
  
GCTGGCTTTTGGCCCTTTGGGTC	
  
GCTGGAGATAGCCCAATACCTGTCC	
  
CCATCTCTTGCCCACTGCTCTTTGG	
  
GGTGACGATGAAGGGCACGTAGAAC	
  
GTCAGCGACGGCAAATACGGAGC	
  
GACCAAGGTTATGGTCAAGGGGGC	
  
CCTCGCTTGTCACGCCCCC	
  
CTCTCGTAGCATAAGCCTCAAGGACAG	
  
CAGACCTTGGGGGAAAAGGGAGCTTTTG	
  
AGACCCACAGGGCAGGTCCTAAG	
  
GTTGAAGTCTATGAGAGGGTTGGGGAC	
  
GAGGGTTACTGATGTCCCGGAAACAC	
  
CCAGGAGAGCTGAACACTGCAAGG	
  
TCTCCTATGACACCGGGGACAAGG	
  
GGCATTTGTTGATCTGGTTTTCAAATCCCAC	
  
CCAGTTTCGGACCAGTTTCAGACCAC	
  
TGTTTAGCCGGAGCACTGTCATGGG	
  
CTCACGCACAGAGCTGCTGGCA	
  
ATGGTTGCACTTGGTGGTCGCTCAG	
  
CTGCATGGCTGTTGGTACGGACTG	
  
GGTTAGAAGTGTCTGCTCTCCAAGAAGA	
  	
  	
  	
  
GGATGAGTATGAGGACAGCCAGTCTC	
  
GGAGAACCTAGAAGACACACTTCCTCC	
  
GTTATAACCCCCAGCCTGAGGCC	
  	
  	
  
GGTCTCTCATGTCAACAAGGCTCGC	
  	
  	
  
AGGAACAACTGGCCAAGAGAAAGACCTT	
  
GCACCATGATGTTATATGGTGTCCAGGT	
  	
  	
  
TCCCTCGACGTACCGCTGGTG	
  
GCGTGGTAGGCGAACGGTGG	
  
CCGTGGCTTGACTCGCGACC	
  
AGGCACTTGCGCACCTTGGGC	
  
ACCATTAACATGGATGGGACCGCCC	
  
CGGCCGTGGCTGTGATGCTTATTG	
  	
  	
  	
  
CATTAACATGGATGGCACAGCCCTTTAC	
  
TGCCCAGGTTTCGGTGCTTTGGC	
  
ACTGTCCTGAGCGGGCTTGCAATC	
  
TGTCAGGAGAGCCTGCGCCATAC	
  
GCCTGCAGACCATGACCCGAG	
  
GAGCTGGTACGGGCGCAAGG	
  
CCGTGGCTTGACTCGCGACC	
  
AGGCACTTGCGCACCTTGGGC	
  
CAGGGTGGCATTTATGTCTTCAAACTGTTTG	
  
ATAGAACCGGTTGACACCATAAAACCAGG	
  	
  	
  	
  

Tm
(°C)
61
61
61
61
61
61
62
61
61
61
61
61
61
61
60
61
61
61
61
61
61
61
60
61
61
60
61
61
60
61
61
61
61
60
60
60
60
60
60
61
61
60
61
61
61
60
60
60
60
60
60

Length
(nt)
119
123
120
119
123
122

120

123
126
120
129
120
120
120
120
120
120
115

117
121
120
117
125
117
123
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Gene Name
Kainate 5
NR1
mGluR5
5HT-1d
5HT-2c
vAChT
vGlut1
vGlut2
VIATT
Cnr1; CB1-Receptor
Adra1a
Adra2b
Htr1b
Htr2a
Gabbr2
Gabrd
Grik3
Chrm5
Chrna7
Sesn3
Hipk2
Add2
Kcnb1
Shc3

Sequence

Tm
(°C)

TCCTGGTTGTCGTTCCTCGGGC	
  
AGCCGGCATCTTCCTCCCCTC	
  
AACAAGCGCGGACCCAAGGCAG	
  
CGCTTGCAGAAAGGATGATGACCCG	
  
TGGCTCTGGCCCCGGTGCA	
  
GAAGCGCTCCTCTGCCTCTGC	
  	
  	
  	
  	
  
CGGTGAACCAGCGGTGACCC	
  
TGGTTCTGTCCTGCTGACGGCTTTG	
  
CGTCGGCGTCGTGGAGATCG	
  
TCCAGCATCTCCGCGCCAATCG	
  
TCCTTCGCGCCCTTAGTGGTCTC	
  	
  	
  
GCCATAGACTGATACGTGGCGCAC	
  	
  	
  
AGAAGCGGCAGGAAGGCGCG	
  
TGTAGCGACGAGGGAGGCCAAAG	
  
TTGGTGCTTGCAGTAGGATTCAGTGGATT	
  	
  	
  
CAGCGTGCCAACGCCATTTGAAATGC	
  	
  	
  	
  
CGCTGAGGCTACGCGAGGTG	
  
CCGAAGCCTCTGTGTGGACATGG	
  
AAGGCTCACAGCCACGCAGTTCG	
  
TAATGTCCATGCGGGCTTGGTCAGG	
  
TGCATCAACCCTATCATATACCCATGCTC	
  
AGTGTAGCCCAGGGCATGCTTGG	
  
CCACCCTTGCAGCAGCCTCAG	
  
GCTCAGCTGTGTCCGACGGC	
  
GAACCAAGTCAAAGTGCGAGTCTCAGAC	
  
GCCAACACACAATAAATGCTCCTAAAATGATCC	
  
GGACGATGCAGTCCATCAGCAACG	
  
TGCAGATGACGGCCATGATATTGGTGATG	
  
GAAGATTCGAAGACCTCCACCTCAGTC	
  
GTCTTTGTCCAGCTCTGTGATCTTCATTC	
  
CAGGAAGAAACGGAAAGCCAAGGTCAAG	
  
GAGATAGCCAACTCCTGACTGACC	
  
CATCGACTCCAAGGGCTATGGCATC	
  
CACTTCTCCTTCATGATGTGCAGTTTGTC	
  
TGTTCCTTCCCAGTGTCCAAAGACCC	
  
CAAGGTCTGCGCCGCTTTCCTCT	
  
CGCTGCAGCCTGGCCAGTGTGGAGC	
  
AGTCTGGAGTTGGGGCACAGTGC	
  
CGAATGGTCTACAATCTCACCTACAACAC	
  
CATAGTCATCATACCTGATTCCAAACATACAGTG	
  
CAGCAGCGCACAGGGCACAAC	
  
TTCACTGGCCTGGGTCTTCAGTGG	
  
GACCACGTGGATGAAGGCTGATGAAG	
  
ATGTCCAGAACTTCCTGGGGGTCAG	
  
AGACTCATGGAGACCAACCCCATCC	
  
GAAGTTAACCTTGAGCGCTCGCAGC	
  
ACGGAAGGACCTCTTTGACATGAAGCC	
  
	
  
	
   GGGGCTCTGGGTGTGACCG	
  

60
60
60
61
60
60
60
61
60
60
61
60
60
61
60
61
60
61
61
61
60
61
60
60
61
61
61
61
61
60
61
61
61
60
61
61
60
61
60
61
60
61
61
61
61
61
61
60

Length
(nt)
117
121
121
117
120
120
120
120
118
120
120
120
120
120
120
120
120
120
120
120
120
120
120
120
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Abstract
Dendritic spines are the postsynaptic sites for the majority of excitatory synapses in
the mammalian forebrain. While many spines display great stability, others change shape in a
matter of seconds to minutes. These rapid alterations in dendritic spine number and size
require tight control of the actin cytoskeleton, the main structural component of dendritic
spines. The ability of neurons to alter spine number and size is essential for the expression of
neuronal plasticity. Within spines, guanine nucleotide exchange factors (GEFs) act as critical
regulators of the actin cytoskeleton by controlling the activity of Rho-GTPases. In this review
we focus on the Rho-GEFs expressed in the nucleus accumbens and localized to the
postsynaptic density, and thus positioned to effect rapid alterations in the structure of
dendritic spines. We review literature that ties these GEFs to different receptor systems and
intracellular signaling cascades and discuss the effects these interactions are likely to have on
synaptic plasticity.

Introduction
In the mammalian forebrain, the vast majority of excitatory synapses (75-90%)
terminate on dendritic spines211,212. While many of these spines are stable, lasting for months
even in vivo, one of the key hallmarks of spines is their lability. Dendritic spine size changes in
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response to a variety of extracellular stimuli. Of particular importance, stimuli that induce
long-term potentiation, believed to be the cellular correlate of learning, result in increases in
both spine size and spine density in ex vivo slice preparations213-217. Additionally, animals that
have undergone training in a fear conditioning paradigm have altered dendritic spine content
and morphology in the amygdala, the brain region responsible for this type of learning218,219.
While alterations in dendritic spine plasticity are important for learning and memory, it
is likely that they play a role in pathological plasticity as well. Chronic treatment with cocaine
or amphetamine increases spine density in the nucleus accumbens (NAc), while chronic
morphine treatment decreases spine density in this crucial region96,99,220-222. In addition to
addiction, various forms of mental retardation and psychiatric conditions such as
schizophrenia have been linked to changes in spine morphology223-228. For example, patients
with fragile X syndrome demonstrate a profound increase in spine density229-232, while a
number of non-syndromic mental retardations show decreases in spine density233,234. Down’s
syndrome patients have significantly decreased dendritic spine density, branching and length
in various cortical subregions223,235. Clearly, tight regulation of spine formation is crucial for
normal neuronal function.
Key to the regulation of dendritic spine formation and function is the actin
cytoskeleton, which makes up the structural core of the spine216,236-240. Actin dynamics are
crucial to the plasticity involved in forming and reshaping new spines. Rho-GTPases, a subfamily of the small GTP-binding proteins, are critical for regulation of the actin cytoskeleton
and myriad other cellular functions115,216,240-243. We focus here on the signaling pathways used
to control these molecular switches at the postsynaptic density.

Control of the Actin Cytoskeleton: Rho Proteins
Rho-GTPases function as tightly regulated molecular switches. In their basal state,
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these proteins are GDP-bound and inactive. Activation is controlled by guanine nucleotide
exchange factors (GEFs), which catalyze the exchange of GDP for GTP. GTP-bound RhoGTPases are active and can form high-affinity interactions with their downstream targets,
regulating target protein activity and localization244. GTPase activating proteins (GAPs), which
accelerate the GTPase activity of their target Rho proteins, return the Rho proteins to their
inactive, GDP-bound state. While there are 61 Rho-GEFs and 68 Rho-GAPs encoded by the
human genome, there are only 20 Rho-family GTPases245 (http://www.uniprot.org/). The gene
tallies differ slightly in the mouse, with 58 Rho-GEFs, 56 Rho-GAPs and 20 Rho-GTPases
(http://www.uniprot.org/). In both species, the excess of GEFs and GAPs over GTPases presents
an interesting regulatory quagmire and puts a premium on sites of expression and subcellular
localization.
Since we are interested in understanding how drugs of abuse hijack the mechanisms
that control synaptic plasticity, we focus on the nucleus accumbens (NAc), a region of the
ventral striatum containing primarily GABAergic medium spiny neurons that receive heavy
dopaminergic innervation from the ventral tegmental area and glutamatergic inputs from the
prefrontal cortex87,184. Based on extensive behavioral data, the nucleus accumbens is
frequently called the “reward center” of the brain94,95,121,246-248. mRNA-Seq technology3 was used
to identify 31 Rho-GEF, 26 Rho-GAP and 14 Rho-GTPase genes whose transcripts are expressed
at significant levels in the adult mouse NAc (Eipper-Mains, J.E., unpublished observations).
Official gene names, synonyms and associated identifiers for all annotated Rho-GEF, Rho-GAP
and Rho-GTPase genes in the mouse genome are provided in Supplementary Table 1.
The epicenter of the dendritic spine is the postsynaptic density (PSD), an electron
dense structure composed of over 500 proteins, including scaffolds, ligand gated ion
channels, receptors and signaling molecules249-251. In order to focus on the Rho-GEFs, GAPs and
GTPases that are localized to the PSD, we compared our list of expressed transcripts to the
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forebrain PSD proteome66,252,253. Ten of the Rho-GEFs expressed at significant levels in the NAc
have been identified in purified PSDs or otherwise localized to the PSD254 (J E-M, unpublished
observations). Official gene names, synonyms and SMART structures of the major neuronal
isoforms for these Rho-GEFs are shown in Fig. 4.1; five terminate with a PDZ-binding motif and
five include an SH3 domain. Of the Rho-GTPases expressed in the NAc, only Rac1 and RhoG
have been localized to the PSD (J E-M, unpublished observations). Localization to the PSD puts
these Rho-GEF/Rho-GTPase pairs in a unique position to respond rapidly to extracellular
stimuli and modify the actin cytoskeleton in a manner dependent on synaptic activity. Of the
Rho-GAPs expressed in the NAc, only 3 are known to localize to the PSD (AU040829, Bcr,
D15Wsu169e) (J E-M, unpublished observations). While Rho-GAPs clearly play an integral part
in the regulation of Rho-GTPase activity, their role in synaptic plasticity is outside the scope of
this review. We focus our review on how the PSD-localized Rho-GEFs are regulated by
extracellular and intracellular signals and the roles they might play in modulating dendritic
spine function.
With respect to dendritic spine dynamics, the best characterized Rho GTPases are
Rac1, RhoA and Cdc42. Within spines, Rac1 and RhoA seem to play antagonistic roles, with
Rac1 promoting spine formation and growth and RhoA promoting spine retraction and
decreases in spine density241,255,256. Cdc42 also promotes spine formation and is present in
spines227,257, but has not been localized to the PSD. We begin with a review of the Rho-GEFs
that preferentially activate Rac1 before moving on to those that activate RhoA and Cdc42.

Rac1-Specific Rho-GEFs
Tiam1
Tiam1 (T-cell lymphoma invasion and metastasis 1) is a Rac1-specific GEF with a single
Dbl homology-pleckstrin homology (DH-PH) domain near its C-terminus, a PDZ-binding motif
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Figure 4.1 Rho-GEFs and Rho-GTPases expressed in the NAc and localized to the PSD
Gene diagrams are drawn to scale and represent SMART structures (http://smart.embl-heidelberg.de/)
with several modifications (see Supplementary Table 2). Abbreviations: C1, Protein kinase C conserved
region 1 (C1); C2, Protein kinase C conserved region 2 (CalB); EH, Eps15 homology domain; IQ, Short
calmodulin-binding motif containing conserved Ile and Gln residues; PDZ, Domain present in PSD-95,
Dlg, and ZO-1/2; PH, Pleckstrin homology domain; RasGEF, Guanine nucleotide exchange factor for Raslike small GTPases; RasGEFN, Guanine nucleotide exchange factor for Ras-like GTPases, N-terminal motif;
RBD, Raf-like Ras-binding domain; RhoGAP, GTPase-activator protein for Rho-like GTPases; RhoGEF,
Guanine nucleotide exchange factor for Rho/Rac/Cdc42-like GTPases; SEC14, Domain in homologues of
a S. cerevisiae phosphatidylinositol transfer protein (Sec14p); SH3, Src homology 3 domains; SPEC,
Spectrin-like repeats.
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at its C-terminus, and an additional PH domain closer to its N-terminus (Fig. 4.1)258.
Additionally, Tiam1 has an internal PDZ domain that binds to the C-terminal peptide sequence
Tyr-Tyr-(Phe/Ala), although neuronal interaction partners have not yet been identified258.
When expressed in fibroblasts, Tiam1 induces membrane ruffling and a morphology
resembling that of constitutively activated Rac1259. Interestingly, it is the more N-terminal PH
domain of Tiam1 that is essential for its membrane localization, and deletion of this domain
leads to cytosolic dispersal and a lack of induced membrane changes260. Studies in
neuroblastoma lines demonstrated that over-expression of Tiam1 increases Rac1-dependent
neurite outgrowth and insensitivity to RhoA-induced neurite retraction261. While Tiam1 was
not identified in purified rat forebrain PSDs66,252, immunogold electron microscopy
demonstrates that Tiam1 is intercalated into the PSD254. This study, which was the first to
examine Tiam1 in primary neurons, demonstrated that Tiam1 is necessary for the elaboration
of a full dendritic arbor. Neurons transfected with RNAi targeted against Tiam1 showed a
dramatic reduction in spine density, and the remaining spines were longer and more
filopodial than spines in control cultures254.
Neurons expressing Tiam1 RNAi also exhibited a sharp decrease in miniature
postsynaptic currents, indicating a functional as well as a morphological change254. The ability
of Tiam1 to interact directly with the NR1 NMDA receptor subunit, but not with any of the NR2
subunits, presumably contributes to this deficit (Fig. 4.2A). Stimulation of NMDA receptors in
control cultures leads to an increase in spine density and size; neurons expressing Tiam1 RNAi
showed no such changes in spine morphology254. This result is particularly compelling because
it presents a strong functional connection for the interaction of Tiam1 and NR1. Further linking
NMDA receptors to Tiam1 signaling, Tiam1 is phosphorylated on unknown Thr residues by
CamKII and protein kinase C (PKC), enhancing its GEF activity about 2-fold262,263 (Fig. 4.2A).
Given that CamKII and PKC are indirectly activated by calcium264,265 and both represent major
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Figure 4.2 Rac-specific GEFs at the PSD
(A) Tiam1 with NR1 subunit of NMDA receptor, EphB and TrkB. (B) Kalirin7 with PSD-95, PI-3-P/PI-3,5-P2,
NR2B subunit of NMDA receptor, EphB, Cdk5, and AF-6/N-cadherin. (C) Arhgef7/β-Pix with
CamKK/CamKI/PKA, GluR2/3 subunit of AMPA receptor via GIT1/liprin-α/GRIP, Pak, Shank, and EphB. (D)
Rasgrf2 with Cdk5, NMDA and AMPA receptors.
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components of the PSD66, the anchoring of Tiam1 to NMDA receptors may enhance the
response of the synapse to the calcium influx that results from NMDA receptor stimulation266.
In addition to NMDA receptors, Tiam1 also forms a stable interaction with the receptor
tyrosine kinase EphB2267 (Fig. 4.2A). EphB2 is stimulated by its presynaptic binding partner
EphrinB, increasing dendritic spine number and size268. Stimulation of cultured neurons with
EphrinB leads to a clustering of Tiam1 at the sites of new synaptic contacts. At these sites,
Tiam1 and EphB2 form a stable complex with EphB2 binding to the N-terminal PH domain of
Tiam1. As a result, EphB2 phosphorylates Tiam1 at Tyr829267 (Fig. 4.2A). In COS7 cells, a
phosphomimetic point mutant at this site leads to an increase in Rac1 activation269.
Importantly, RNAi knockdown of Tiam1 ablates the ability of activated EphB2 to increase spine
formation in cultured hippocampal neurons, indicating that this pathway is Tiam1dependent267. The interaction of Tiam1 with both NMDA receptors and EphB2 begins to paint
an interesting picture of an important molecular complex at the PSD. EphB2 has repeatedly
been shown to be important for NMDA receptor clustering and function270-273. Additionally,
stimulation of both EphB2268,270 and NMDA receptors274 has been implicated in the growth and
formation of new spines. As a direct interactor with both proteins, Tiam1 is well-positioned to
integrate voltage-sensitive, ligand-gated ion channel signaling and receptor tyrosine kinase
signaling to effect activity-dependent changes in the actin cytoskeleton.
Finally, Tiam1 interacts with another receptor tyrosine kinase, TrkB269 (Fig. 4.2A). The
binding of BDNF to TrkB has long been known to be important for the formation and
maturation of synapses275. Tiam1 interacts with TrkB via its N-terminal PH domain and is
phosphorylated on Tyr829 (as with EphB2)269. Expression of a non-phosphorylatable Tiam1
mutant (Tyr829Phe) blocked the BDNF-induced increase in dendritic spines, demonstrating an
essential role for phosphorylation at this site269. Although a Tiam1 knockout mouse has been
created and is viable276, it has primarily been used for cancer research.
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Kalirin7
In the adult brain, Kalirin7, with a single GEF domain specific for Rac1 and RhoG, is the
most abundant splice variant of the Kalrn gene277,278 (Fig. 2.1); several larger Kalirin isoforms,
with a second GEF domain specific for RhoA, are expressed at lower levels, but are not
localized to the PSD279-282. Kalirin7 terminates with a PDZ-binding motif and it is estimated that
the average hippocampal PSD, which contains about 20 NMDA receptors and 15 AMPA
receptors249, contains 10 copies of Kalirin7133. At the N-terminus of Kalirin7 is a Sec14p domain
that binds phosphatidylinositol-3-phosphate and phosphatidylinositol-3,5-bisphosphate and
is essential for membrane localization283; this is followed by 9 spectrin-like repeats (Fig. 2.1 and
2.2B).
A yeast two-hybrid screen with the PDZ-binding motif of Kalirin7 identified 16 PDZ
domain-containing interactors284. Given that these PDZ domain-containing proteins interact
with a variety of receptor subtypes (e.g. NMDA, AMPA, 5-HT), protein kinases (e.g. PKA, CamKII)
and filamentous actin, this places Kalirin7 in a unique position to integrate a wide variety of
signals at the PSD285. The interaction of Kalirin7 with PSD-95 decreases its ability to activate
Rac1 (Fig. 2.2B). Kalirin7 was identified in the NMDA receptor interactome after affinitypurification using a peptide from the C-terminus of the NR2B subunit66; this interaction was
verified by co-immunoprecipitation of Kalirin7 with NR2B (Kiraly, D.D., unpublished
observations). Consistent with this, PSDs purified from mice lacking Kalirin7 have decreased
levels of NR2B133. Unlike Tiam1, Kalirin7 does not co-immunoprecipitate with NR1254. Tiam1,
through its association with the NR1 subunit254, and Kalirin7, through its association the NR2B
subunit, may serve to modulate critical signaling steps downstream of specific NMDA receptor
subsets.
The ability of Kalirin7 to increase spine formation in vitro has been demonstrated in
cultured cortical and hippocampal neurons284,286,287. Perhaps most compelling, Kalirin7
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expression in otherwise aspiny interneurons leads to the formation of spine-like structures
that acquire apposing presynaptic terminals and appear to function as active synapses288.
Recently, these findings were validated in vivo with the development of a Kalirin7 knockout
mouse. These mice display a decrease in dendritic spine density in the hippocampus as well as
impaired hippocampal LTP and focal hippocampus-dependent learning impairments133.
Much has been done to clarify the intracellular molecular interactors with Kalirin7. In cultured
cortical neurons, Kalirin7 is essential for EphB2-induced spine formation287,289 (Fig. 2.2B).
Stimulation of cell cultures with clustered EphrinB led to a modest tyrosine phosphorylation
signal on Kalirin7, although the location of the phosphorylated residue was not established287.
Kalirin7 and Tiam1 may work in parallel pathways to propagate signals downstream of this
receptor tyrosine kinase.
It has been suggested that the N-terminus (Thr95) of Kalirin7 is phosphorylated by
CamKII and that phosphorylation at this site is essential for Kalirin7 to display GEF activity290
(Fig. 2.2B). However, mutation of Thr95, which is not a consensus CamKII site264,291,292, to a nonphosphorylatable Ala (Thr95Ala) did not eliminate its GEF activity, and the GEF activity of
Kalirin7 and shorter splice variants lacking this region (ΔKal7) are indistinguishable in
vitro283,293,294. Co-immunoprecipitation of Kalirin7 and GluR1 led Xie and colleagues to
hypothesize that Kalirin7 is necessary for the movement of GluR1 into newly formed dendritic
spines upon NMDA receptor stimulation of cortical cultures290. Mice genetically lacking Kalirin7
have normal levels of GluR1 in both tissue homogenates and purified PSDs133, so Kalirin7 is not
essential for AMPA receptor localization in vivo.
The Kalirin7 PDZ-binding motif interacts with the PDZ domains of AF-6/Afadin,
Neurabin and Spinophilin, each of which can bind directly to filamentous actin. AF-6 also
mediates the interaction of Kalirin7 with N-cadherin, a trans-synaptic protein that forms
homophilic interactions with presynaptic N-cadherin284,295 (Fig. 2.2B). N-cadherin plays an
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important role in the regulation of dendritic spine morphology296,297. Stimulation of neuronal
cultures with clustered N-cadherin results in an increase in dendritic spine size and recruits AF6, Kalirin7 and Rac1 into dendritic spines295. When expression of all isoforms of Kalirin was
reduced using RNAi, clustered N-cadherin was no longer able to change dendritic spine
morphology295.
Kalirin7 is phosphorylated at a single site (Thr1590) by Cdk5 (Fig. 2.2B), a synapticallylocalized serine/threonine kinase known to play an important role in synapse development
and modulation; Cdk5 is localized to membranes and activated by binding to p35 or p39, not
to a cyclin114,120,294,298-303. Phosphorylation of Thr1590 increases the GEF activity of Kalirin, with the
phosphomimetic mutant (Thr1590Asp) showing a two-fold increase in activity over the nonphosphorylatable mutant (Thr1590Ala). Mutation of Thr1590 to Asp or Ala did not affect the ability
of Kalirin7 to increase spine density. While neurons expressing Thr1590Asp-Kalirin7 exhibited
increased dendritic spine size, neurons expressing Thr1590Ala-Kalirin7 did not294. The fact that
Kalirin7 knockout mice show a decrease in Cdk5 levels in purified synaptosomes and PSDs133
suggests a role for reciprocal regulation of Kalirin7 and Cdk5 in vivo as well as in vitro.

Arhgef7/β-Pix
Arhgef7 (β-Pix) was identified based on its ability to activate Rac1, Cdc42 and Pak (p21
activated kinase)304 (Fig. 2.2C). Two isoforms of β-Pix, β1 and β2, which differ only at their Ctermini, are the major ones expressed in the mammalian brain305. The β1 isoform C-terminus
has a coiled-coil domain and a PDZ-binding motif while the β2 isoform C-terminus has a
serine-rich region (Fig. 2.2C)305. The N-terminal SH3 domain of β-Pix binds to Pak, recruiting
Pak to Rac1- and Cdc42-induced adhesion complexes; mutations that inactivate this SH3
domain lead to mislocalization of Pak304. Crystal structure analysis detailed the interactions of
the SH3 domain of β-Pix with Pak306. β-Pix is phosphorylated by Pak on Thr526, increasing its
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membrane localization and boosting its GEF activity, ultimately eliciting neurite formation in
PC12 cells307.
When studied in primary hippocampal cultures, it became clear that β-Pix is recruited
to synapses by GIT1 (G-protein-coupled receptor-kinase-interacting protein 1), which is
present in the PSD66,308. GIT1 is a ubiquitously expressed ARF-GAP (ADP-ribosylation factor
GTPase Activating Protein) that is enriched at the PSD and complexes with AMPA receptor
subunits in the rat brain through its association with liprin-α309. Liprin-α is a multi-functional
protein with a number of known interacting proteins including the GRIP/ABP family
(glutamate receptor interacting proteins) of multi-PDZ domain containing proteins. Through
their PDZ domains, GRIPs at the PSD interact with a number of different proteins including the
AMPA receptor subunits GluR2 and GluR3, the receptor tyrosine kinase EphB2 and the
neuronal Ras-GEF GRASP-1309,310.
The GIT1-binding domain of β-Pix lies just upstream of the C-terminal coiled-coil and
the C-terminal serine-rich regions of β1- and β2-Pix, respectively305. The ability of GIT1 to
recruit β-Pix to synapses is necessary for the formation of new dendritic spines with apposing
presynaptic terminals. When the β-Pix-binding domain of GIT1 was deleted, β-Pix showed a
more diffuse localization, leading to a multitude of aberrant cell protrusions that were not
associated with presynaptic terminals. The GEF activity of β-Pix is necessary for the formation
of new spine-like structures in hippocampal neurons308. GIT1 is not solely responsible for the
localization of β-Pix to synapses. β1-Pix binds to the PDZ domain of Shank via its C-terminal
PDZ-binding motif250 or its coiled-coil domain311 and over-expression of Shank recruits
additional β-Pix to dendritic spines311 (Fig. 2.2C), blocking actin bundling312. While β-PIX does
not interact with the PDZ domains of PSD95, Sap97, S-Scam, GRIP1, Lin7 or Densilin, it directly
interacts with the PDZ domain of Scribble, a protein most studied in cancer biology and
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epithelial polarity; in PC12 cells stimulated with KCl, Scribble recruits β-Pix to the plasma
membrane313.
β-Pix modulates Ca2+-dependent intracellular signaling. β-Pix co-immunoprecipitates
with CamKK (CamK-kinase) in transfected cells and rat brain lysates314. This interaction is
mediated via the SH3 domain of β-Pix, the region also known to interact with Pak. β-Pix is
phosphorylated by CamKI, a downstream target of CamKK, on Ser516, a site known to be
phosphorylated by PKA315. The GEF activity of β-Pix is stimulated in a Ca2+-dependent manner
and mutation of Ser516 to a non-phosphorylatable mutant (Ser516Ala) obviated the Ca2+dependent changes in Rac1 activation314. Expression of dominant negative CaMKI, Ser516AlaβPIX, or siRNA for either CaMKI or β-Pix resulted in a marked decrease in dendritic spine
density in cultured neurons314. This study clearly demonstrates a role for β-Pix in calciumcalmodulin signaling cascades.
While β-Pix has not been directly linked to any cell-surface receptor in mammals,
deletion of the corresponding Drosophila gene leads to decreased synaptic levels of the
glutamate receptor subunit GluRIIA316. In mice, β-Pix is linked to GluR2/3 AMPA receptor
subunits via the GIT1/liprin-α/GRIP complex described above. Disruption of the GIT1/liprin-α
interaction results in decreased AMPA receptor clustering in cultured neurons309. Taken
together, the Drosophila and mouse data suggest a role for β-Pix in proper postsynaptic AMPA
receptor targeting via its interaction with GIT1/liprin-α/GRIP. Additionally, GIT1 is indirectly
recruited to synapses by EphrinB stimulation of the EphB2 receptor tyrosine kinase317. Three
PSD Rho-GEFs, β-Pix, Tiam1, and Kalirin7, mediate morphogenic signals downstream of
EphB2267,287,318,319.

Rasgrf2
Rasgrf2 is unique in that it contains both a Rho-GEF DH-PH domain as well as a Ras-
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GEF domain (Fig. 2.1). Rasgrf2 has a C-terminal type II PDZ-binding motif with no known
binding partners245. Ras promotes the creation of larger spines receiving excitatory synapses
and is normally held in check by SynGAP320. Interestingly, Rasgrf2 has been linked to the
Cdk5/p35 signaling pathway in neurons. Cdk5 phosphorylates Rasgrf2 on Ser737, decreasing its
Rac1-GEF activity, but has no effect on its ability to activate Ras321 (Fig. 2.2D). Additionally,
while Rasgrf2 is typically found along dendrites in basal conditions, co-expression of p35 and
Cdk5 leads to the retraction of Rasgrf2 into the cell soma321. This is another indication of the
many ways in which Cdk5 activity affects PSD-GEF function. The Ras-GEF domain of Rasgrf2
has been implicated in the control of both NMDA and AMPA glutamate receptors, but will not
be discussed here as we are focusing on Rho-GEFs at the PSD322-324.

RhoA/Cdc42-Specific Rho-GEFs
Ngef/Ephexin1
In the NAc, transcripts encoding Ngef (Ephexin1) are more prevalent than those
encoding any other Rho-GEF (JE-M, unpublished observations). Ephexin1 has C-terminally
located DH, PH and SH3 domains (Fig. 4.1). Ephexin1 activates Rac1, Cdc42, and RhoA325;
different signaling pathways shift its specificity towards Rac1/Cdc42 or towards RhoA, altering
the downstream response. Ephexin1-mediated activation of Rac1 has been studied in the
context of axon outgrowth and neuronal development325-328. While the events leading to Rac1
activation by the Rho-GEFs discussed above are generally well characterized, the events
involved in Ephexin1-mediated Rac1 and Cdc42 activation are not well understood. Pak, which
is involved in β-Pix activation of Rac1, demonstrates increased activity in the context of
Ephexin1-mediated axonal outgrowth325. Pak may complex with Ephexin1 and shift its GEF
activity towards Rac1/Cdc42 activation and actin polymerization325 (Fig. 4.2A).
A great deal more is known about the role of Ephexin1 in RhoA activation. The
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generation of an Ephexin1 knockout mouse facilitated studies into the role of Ephexin1 in
axonal outgrowth and growth cone collapse in cultured retinal ganglion cells (RGCs)326.
Ephexin-/- RGCs exhibit the same number of neurites per cell but have significantly shorter
axons than their wild-type counterparts326. Incubation of Ephexin1-/- RGCs with EphrinA1 does
not elicit the wild-type phenotype of growth cone collapse, implicating an EphA4/Ephexin1
interaction in the control of EphrinA1-induced growth cone collapse. It should not go
unmentioned that Ephexin1 knockout mice show no overt axonal phenotype in vivo326,
perhaps due to functional redundancy amongst RhoGEFs.
The DH-PH domain of Ephexin1 binds the kinase domain of EphA4 in cultured
fibroblasts325; a direct interaction between EphA4 and Ephexin1 has not been demonstrated
by co-immunoprecipitation in neurons326. Ephexin1 is phosphorylated following EphrinA1
stimulation of EphA4 receptors, and this phosphorylation event is required for growth cone
collapse in cultured RGCs326. Stimulation of the EphA4 receptor by EphrinA1 in neuronal
cultures results in EphA4 autophosphorylation and recruitment of two kinases, Cdk5/p35 and
Src, to EphA4 at the PSD301,327. EphrinA1 binding causes a loss of dendritic spines and a
corresponding decrease in miniature excitatory postsynaptic current (mEPSC) frequency301.
The EphA4 receptor co-immunoprecipitates with Cdk5/p35 from rat brain extracts, suggesting
a direct interaction in vivo301.
Activated EphA4 phosphorylates the recruited Cdk5, stimulating its kinase activity and
its subsequent phosphorylation of Ephexin1 at three sites, Thr41, Thr47, and Ser139301 (Fig. 4.3A).
Mutant Ephexin1, in which the Cdk5 target residues are replaced with non-phosphorylatable
Ala residues, eliminates the ability of Src to phosphorylate Ephexin1 on Tyr87; Ephexin1 with
Glu at these same sites supports robust EphrinA1/EphA4-mediated Ephexin1 phosphorylation
at Tyr87301. The kinase domain of EphA4 does not directly phosphorylate Ephexin1 at Tyr87326.
Rather, EphA4 and Src demonstrate ligand-induced association with subsequent stimulation
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Figure 4.3 Rho/Cdc42-specific GEFs at the PSD
(A) Ngef/Ephexin1 with Pak, EphA4, Src, and Cdk5. (B) Arhgef2/Lfc/GEF-H1 with a microtubule,
Spinophilin, GluR1 subunit of AMPA receptor, ERK1/2, AKAP121/PKA, and 14-3-3. (C)
Arhgef9/Collybisitin with Gephyrin and Neuroligin-2. (D) Itsn1/Intersectin-L with N-WASP, EphB2, and
Arp2/3.
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of the tyrosine kinase activity of Src327. Activated Src phosphorylates Ephexin1 at Tyr87, an
event that shifts the GEF activity of Ephexin1 towards RhoA and ultimately results in growth
cone collapse326,329 (Fig. 4.3A). Inhibition of Src-dependent phosphorylation of Ephexin1 at
Tyr87 obviates EphrinA1/EphA4-induced repulsive axon guidance in retinal axons327. Similarly,
analysis of hippocampal cultures from Cdk5-/- mice, revealed an obligatory role for Cdk5 in the
EphrinA1-mediated loss of dendritic spines and decrease in mEPSC frequency301.
There is evidence in cultured cells that the FGF and EphA receptors form heterooligomers and cross-activate one another330. Activated FGF receptor phosphorylates Ephexin1
at several tyrosine residues, including Tyr87, and shifts its GEF activity towards RhoA329. While
the FGF receptor is known to be present at presynaptic terminals and is expressed in
astrocytes331, it is not present at the PSD66,252 and is thus unlikely to play a major role in
dendritic spine actin dynamics.

Arhgef2/Lfc/GEF-H1
Arhgef2 (Lfc; GEF-H1) is a RhoA-specific GEF with a single DH-PH domain and two
coiled coil regions near its C-terminus332 (Fig. 4.1). Under basal conditions Lfc is found
predominantly in dendritic shafts, where it interacts with microtubules via its PH domain332,333.
In cultured neurons, NMDA receptor activation causes the rapid translocation of Lfc into
dendritic spines333 (Fig. 4.3B). A recent study examining Lfc localization in primate cortex at
the electron micrograph level also concluded that Lfc was primarily localized to dendritic
shafts under basal conditions, translocating rapidly into spines upon synaptic stimulation334.
Once in spines, Lfc interacts with Spinophilin and Neurabin, which bind filamentous actin333
(Fig. 4.3B). One study, by Ryan and colleagues, demonstrated that over-expression of Lfc in
cultured neurons produces a decrease in spine size and an increase in spine density333.
Consistent with this, a more recent study by Kang and colleagues demonstrated that
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expression of dominant negative Lfc or shRNA targeted to Lfc increased spine size335. However,
in the more mature cultures studied by Kang and colleagues, reductions in Lfc action
increased spine density, perhaps suggesting developmental alterations the Lfc/RhoA
pathway335. Activation of RhoA has typically been associated with decreased spine
density241,336.
Even under basal conditions, Kang and colleagues found Lfc in the PSD, a finding
supported by PSD proteomics studies66,252. Based on both proteomic analyses of AMPA
receptor complexes and co-immunoprecipitation with the GluR1 and GluR2 AMPA receptor
subunits, Lfc interacts with AMPA receptors. Incubation of hippocampal cultures with an
AMPA receptor antagonist normally leads to a decrease in dendritic spine density; in neurons
expressing Lfc-shRNA, this effect is ablated335. Suppression of AMPA receptor function
normally increases RhoA activity; this response is diminished when Lfc expression is reduced
using Lfc-shRNA, and stimulation of AMPA-R inhibits Lfc activity and RhoA signaling335 (Fig.
4.3B). Lfc seems to play a crucial role in RhoA-mediated spine retraction.
The GEF activity of Lfc is also controlled by phosphorylation337-339. Phosphorylation by kinases
Aurora A/B (at Ser885) or Cdk1/Cyclin B (at Ser959) decreases Lfc-RhoGEF activity337 while
phosphorylation by ERK1/2 (at Thr678) enhances Lfc-RhoGEF activity338. PKA phosphorylates
Ser885, with concomitant AKAP121 binding to Lfc in HEK293 cells; the phospho-specific
scaffolding protein, 14-3-3, then binds to P-Ser885-Lfc, decreasing the GEF activity of Lfc340 (Fig.
4.3B). Though proteomics studies have localized PKA to the PSD66,252, the role of PKAdependent phosphorylation in the regulation of Lfc-RhoGEF activity in neurons remains to be
studied.

Arhgef9/Collybistin
Arhgef9 (Collybistin) is a brain-specific Rho-GEF with a single DH-PH domain that is
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specific for Cdc42341 (Fig. 4.1). Two isoforms of Collybistin are expressed in brain: Collybistin1
includes an N-terminal SH3 domain and a C-terminal coiled-coil domain; Collybistin2 lacks
these two domains342. Although the identities of the specific players regulating CollybistinRhoGEF activity and localization remain elusive, it is clear that its SH3 domain plays a key role
in these interactions343.
Collybistin is expressed broadly throughout the forebrain and cerebellum from early
embryonic life through adulthood342,344. Collybistin was originally discovered as an interactor
with Gephyrin, a protein essential for the formation of inhibitory postsynaptic structures in
brain and spinal cord341,342. The linker region between the SH3 and DH domains is essential for
the Collybistin-Gephyrin interaction345 (Fig. 4.3C). Collybistin with an active PH domain and an
intact Gephyrin-binding site is essential for the postsynaptic localization of Gephyrin in
dendrites of cultured cortical neurons343. A patient exhibiting hyperekplexia and epilepsy,
both potentially caused by a decrease in inhibitory neurotransmission, had a mutation that
disrupted the SH3 region of Collybistin343. Expression of this mutant protein in cultured cortical
neurons led to a loss of GABAA receptor clustering343. Another patient with a balanced
chromosomal translocation leading to disruption of the Collybistin gene displayed disturbed
sleep cycles, increased anxiety, epileptic seizures and mental retardation346. Collybistin clearly
plays a key role in the regulation of inhibitory transmission in humans as well as rodents.
The Collybistin knockout mouse displays normal locomotor activity, but anxiety-like
behavior is increased dramatically and spatial learning is grossly impaired347. In the
hippocampus and amygdala of the Collybistin-/- mouse, GABAA receptor expression is greatly
reduced and inhibitory neurotransmission is decreased. Interestingly, these mice display
enhanced CA1 LTP in hippocampal slices while LTD plasticity is impaired347. In contrast,
induction of LTP in the dentate gyrus of Collybistin-/- mice is greatly decreased348. Both
Collybistin and Gephyrin interact with Neuroligin-2, a trans-synaptic scaffolding protein
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essential for the formation of inhibitory synapses349 (Fig. 4.3C). The interaction of Collybistin
and Neuroligin-2 enhances the ability of Collybistin to recruit Gephyrin to synapses, which in
turn leads to the formation of more inhibitory synapses in cultured neurons349. Taken together,
these studies demonstrate a clear role for Collybistin in the normal formation of inhibitory
synapses and the balance of excitatory/inhibitory transmission in the mammalian forebrain,
but leave unanswered the role of the GEF domain of Collybistin in the nervous system.

Itsn1/Intersectin-L
The longer neuron-specific splice variant of the Itsn1 gene, Intersectin-L, includes Cterminal DH, PH and C2 domains as well as several common protein-protein interacting
regions it shares with the shorter, ubiquitously expressed splice variant, Intersectin-S350-352 (Fig.
4.1). The common region includes two Eps15 homology domains, several coiled-coil regions,
and five SH3 domains. Intersectin-S affects neuronal endocytic vesicle formation352. The
tandem DH-PH domains of Intersectin-L interact specifically with Cdc42 to stimulate its
GTPase activity, and over-expression of Intersectin-L induces formation of filopodia in
fibroblasts350.
Regulation of the Rho-GEF activity of Intersectin-L occurs at many levels. Activity
assays demonstrate more robust GEF activity in C-terminal DH-PH tail constructs than in fulllength Intersectin-L, suggesting a role for N-terminal modulation of the GEF activity of
Intersectin-L. N-WASP (Neuronal Wiskott-Aldrich Syndrome Protein), which activates the
Arp2/3 actin-nucleating complex, interacts directly with the SH3 domains of Intersectin-L,
stimulating its GEF activity; the Intersectin-L/N-WASP complex can be immunoprecipitated
from transfected cells and from native brain extracts350 (Fig. 4.3D). The N-WASP/Intersectin-L
interaction relieves Intersectin-L autoinhibition and may stabilize the GEF domain interaction
with GDP-bound Cdc42, catalyzing its activation350. Additionally, the kinase domain of the
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receptor tyrosine kinase EphB2 interacts with the N-terminus of Intersectin-L, activating Cdc42
in hippocampal neurons; the Intersectin-L/ EphB2 complex can be immunoprecipitated from
extracts of transfected cells353 (Fig. 4.3D).
N-WASP links Cdc42 to the actin cytoskeleton via its ability to stimulate the Arp2/3
complex, causing actin-nucleation239,350,354. Co-localization of EphB2 and N-WASP with
Intersectin-L and F-actin in dendritic spines suggests a model in which EphB2 and N-WASP act
synergistically to activate Intersectin-L GEF activity352,353 (Fig. 4.3D). Concomitant binding of NWASP to the Intersectin-L/Cdc42 complex results in relief of N-WASP autoinhibition and a
dose-dependent N-WASP-mediated stimulation of Intersectin-L GEF activity239,350. Activated NWASP stimulates the Arp2/3 complex, causing actin polymerization239,350. N-WASP plays roles
both up- and downstream of Intersectin-L, highlighting the importance that multimolecular
complexes play in the regulation of the actin cytoskeleton355.
The Itsn1 gene has been implicated in Down Syndrome (DS), with DS neurons exhibiting
abnormal dendritic spine morphology and altered endosomal pathways351. The Itsn1 gene is
located on human chromosome 21, the same chromosome present in extra copy number in
Down Syndrome, further suggesting a role for Itsn1 in the pathophysiology of Down
Syndrome352.

Bcr
Bcr (Breakpoint cluster region) negatively regulates cell proliferaton and oncogenic
transformation356. Bcr and the closely related protein Abr are the only two GTPase-activating
proteins that specifically inactivate Rac1357. Bcr both turns Rac1 on (via its GEF domain) and
inactivates Rac1 (via its RhoGAP domain) (Fig. 4.1). Bcr exhibits GEF activity towards Rac1,
Cdc42, and RhoA245. In addition to its DH-PH and GAP domains, Bcr has a serine/threonine
kinase domain and a C-terminal PDZ-binding motif that interacts with the PDZ domain of AF-
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6/Afadin, a protein known to bind Ras and filamentous actin356. The kinase domain of Bcr
phosphorylates AF-6 near its PDZ domain, promoting a direct interaction between Bcr and AF6356. While the impact of the Bcr/AF-6 interaction on the GEF activity of Bcr remains to be
determined, the existence of this phosphorylation-mediated interaction raises the possibility
that phosphorylation events can regulate interactions between other PDZ-binding motifcontaining Rho-GEFs and their PDZ-domain-containing partners245.
Bcr is among a set of genes expressed very early in development358. Full-length Bcr contributes
to NGF-independent neurite formation in PC12 cells359, while a fusion construct including the
GEF domain but not the RhoGAP domain suppresses neurite outgrowth359. Mice in which both
Bcr and Abr are knocked out show a number of glial cell developmental abnormalities which
then precipitate neuronal abnormalities in the cerebellum and midbrain360. A genomic
translocation resulting in a fusion between Bcr and the Abl kinase is seen in 95% of patients
with chronic myelogenous leukemia (CML)361.

Conclusions
As primary regulators of the actin cytoskeleton, Rho-GEFs play the role of conductors
in the elegant symphony that is synaptic plasticity. A preponderance of human and animal
studies demonstrate that a dynamic balance of synapse formation and elimination is
necessary for normal cognition and neuronal function. The delicate balance that is struck
between GEF-GTPase activity and the actin cytoskeleton includes several GEFs regulated by
the same pathways. A number of GEFs have been shown to be downstream of NMDA
receptors (Tiam1, Kalirin7, Rasgrf2, Lfc) and/or Ephrin receptors (Tiam1, Kalirin7, β-Pix,
Ephexin1, Intersectin-L), two receptor systems critically linked to the plasticity of the
postsynaptic neuron319,362. Additionally, while all of these proteins have been linked to a variety
of intracellular signaling cascades, it is noteworthy that a number of them (Kalirin7, Rasgrf2,
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Ephexin1) have been linked to Cdk5, a protein known to have myriad effects on the structure
and function of PSDs and spines120,301,303,363. Additionally, Tiam1, Kalirin7 and β-Pix have all been
linked to calcium-calmodulin kinase signaling pathways, which have a plethora of functions at
the synapse and play essential roles in synaptic plasticity264,314. Clearly, this puts a premium on
localization of the GEF, its target GTPase, and any other signaling molecules that influence
their function.
One of the quandaries raised by this review of the literature is the disparity between
cell culture studies and in vivo models of these Rho-GEFs. While cell culture studies may
indicate that a specific Rho-GEF is “essential” for dendritic spine formation254,286, the phenotype
observed in the corresponding knockout animal is often much less profound. Taking Kalirin7
as an example, cultures expressing shRNA for Kalirin7 have almost no normal dendritic
spines288; however, Kalirin7 knockout mice display only a 20% decrease in hippocampal spine
density. While neither the cell culture nor constitutive knockout system is without its
drawbacks, the disparity between these types of studies suggests that serious consideration
should be made before interpreting any of these findings in a translational or clinical sense. As
new and developing technologies (mRNA-Seq, proteomics, phosphoproteomics, etc.) become
more affordable and accessible to researchers, they will facilitate the integration of seemingly
solitary signaling pathways into the overlapping web of pathways that is likely occurring in
vivo.
While extensive research has pushed our understanding of dendritic spines forward,
there is clearly still much more that needs to be determined. Localizing activated Rho-GEFs
and Rho-GTPases and understanding the kinetics of their activation and inactivation will be
critical. It will be important to clarify the conditions under which different receptors activate
different Rho-GEFs and how they interact with their target Rho-GTPases. It is only through the
clarification of these networks that we will be able to determine their precise role in mental
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retardation, drug addiction, schizophrenia or the host of other human pathologies that
demonstrate altered synaptic connectivity.

Online Supporting Material
Supplementary tables are available online at:
http://intron.ccam.uchc.edu/data/pipeline/jodi/THESIS_supplementary_files/CHAPTER_4
These materials are also available at the journal of publication:
http://pubs.acs.org/doi/suppl/10.1021/cn100012x

Supplementary table legends
Supplementary Table 1: Names and accession numbers for all identified M. musculus RhoGEFS, Rho-GAPs, and Rho-GTPases expressed in the PSD.
Gene Symbol, Gene Name, MGI ID, and Entrez ID represent the official names and identifiers
for each gene as designated by the naming authority. MGI ID and Entrez ID entries are
hyperlinked to the specific gene page the Mouse Genome Informatics (MGI) and NCBI
(GenBank) websites. Table includes Synonyms, UniGene IDs, UniProt ID, UniProt Accession,
Ensemble IDs, and RefSeq IDs.

Supplementary Table 2: Modifications to SMART structures of Rho-GEFs in Fig. 4.1.
Features changed from SMART database (http://smart.embl-heidelberg.de/) structures are
provided for each Rho-GEF in Fig. 4.1. Table includes the accession number used in the SMART
query and provides a reference in support of the changes. Accession numbers are from the
UniProt (http://www.uniprot.org/) and NCBI (http://www.ncbi.nlm.nih.gov/protein) databases.
SMART designates segments of low compositional complexity, all of which were removed
from the gene structures in Fig. 4.1.
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CHAPTER 5
Collaborative Bioinformatic Projects

Introduction
Collaborative work has been an invaluable part of my graduate education. Through
collaborative efforts I have been able to explore a number of aspects of biology that I
otherwise might not have. This chapter provides a brief compilation of some of the additional
computational work I have done in collaboration with others, much of which has resulted in
the generation of published studies.

Alternative exon classification
The first year of my time in graduate school was spent learning the basics of Perl
scripting. My first assignment was the characterization of the transcribed elements of the fruit
fly (Drosophila melanogaster), mouse (Mus musculus), and human (Homo sapiens)
transcriptomes. I generated Perl scripts that processed the annotated genes and created files
with the following alternative exon event classifications: alternative 5’ and alternative 3’ splice
sites, alternative initiation and termination exons, retained/unprocessed introns, cassette
exons, mutually exclusive exons, and coordinate exons (Fig. 5.1).
My classification of alternative and constitutive regions of the Drosophila genome was
used in the generation of two recent publications364,365:
McManus, C.J., Duff, M.O., Eipper-Mains, J. & Graveley, B.R. Global analysis of trans-splicing in
Drosophila. Proc. Natl. Acad. Sci. U.S.A. 107, 12975-12979 (2010).
McManus, C.J., et al. Regulatory divergence in Drosophila revealed by mRNA-seq. Genome Res.
20, 816-825 (2010).
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Figure 5.1 Classification of common types of alternative splicing events
Depiction of the alternative splicing events determined by the Perl script I wrote. Constitutive exons are
shown in blue and alternatively spliced exons are shown in yellow.
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Two ongoing projects in the lab are making use of the complete classification of
Drosophila and Homo transcribed regions for the analysis of alternative splicing. I wrote
additional Perl and R-programming language scripts to analyze splice junction usage and/or
exclusion and to provide an output containing a statistical measure of significance (Fisher’s
Exact Test). These studies are expected to result in publications in the near future.

Analysis of alternate promoter usage in the Kalrn gene
Because of my familiarity with the UCSC Genome Browser, I was asked to assist with
analysis of the effects of cocaine on a specific Rho GDP/GTP exchange factor (GEF), Kalrn. For
this paper, I performed many of the necessary bioinformatic analyses. This included
identification and extraction of alternative promoter sequences, characterization of exons, and
identification of the corresponding protein domains.
Chronic cocaine exposure induces lasting morphological changes at excitatory
glutamatergic synapses on medium spiny neurons of the striatum87. Modifications to synaptic
morphology are carried out through rearrangements of the actin cytoskeleton and are largely
mediated by the activation of the Rho family of proteins68. The Kalrn gene exhibits complex
alternative splicing and multiple distinct isoforms with different functional domains are
expressed throughout the body280,281. Full-length Kalrn has two GEF domains, through which it
activates Rho proteins, as well as additional protein interacting domains277.
Chronic cocaine exposure leads to increased expression of a specific Kalirin isoform,
Kalirin 7, in the striatum. Mice specifically lacking this isoform, which is the major Kalrn isoform
in the adult rodent brain, exhibit behavioral abnormalities and lack the increased dendritic
spine density normally observed following chronic cocaine exposure98.
I contributed a figure detailing the complex alternative splicing pattern seen in the
Kalrn gene (Fig. 5.2).

Figure 5.2 Structure of the mouse Kalrn gene and major transcripts
Genomic and transcript information was compiled from websites (http://www.ensembl.org/Mus_musculus/Info/; http://genome.ucsc.edu/cgi-bin/) and
previously published work (Johnson et al., 2000, McPherson et al., 2002, and McPherson et al., 2004) to create an accurate map of the mouse Kalrn gene and
the major brain transcripts277,280. Protein domains (http://smart.embl-heidelberg.de/) encoded by groups of exons are indicated.
(Appeared in its original form as Figure 2 from Mains, R.E., Kiraly, D.D., Eipper-Mains, J.E., Ma, X. & Eipper, B.A. Kalrn promoter usage and isoform expression
respond to chronic cocaine exposure. BMC Neurosci.12, 20 (2011)).
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This work appeared in a recent publication116:
Mains, R.E., Kiraly, D.D., Eipper-Mains, J.E., Ma, X. & Eipper, B.A. Kalrn promoter usage and
isoform expression respond to chronic cocaine exposure. BMC Neurosci 12, 20 (2011).

EMBOSS silent restriction sites
I installed, compiled, and executed the EMBOSS silent program
(http://emboss.bioinformatics.nl/) to identify potential silent restriction site modifications for
use in the introduction of specific mutations and features in protein coding genes. These
contributions are in use in a number of ongoing projects in another lab and will likely be
included in future publications.

CHAPTER 6
Conclusions & Future Directions

Introduction
Global analytical approaches generate enormous amounts of data, creating new
opportunities to address important questions in fundamentally different ways. The studies
described in the previous chapters provide a framework for many future experiments.

Experimental approaches
The data presented in this thesis were collected over a period of years on a relatively
limited number of experimental animals, using slightly different cocaine treatment paradigms
and techniques, and two different sequencing machines. Ideally, these experiments could be
carried out with larger numbers of mice receiving identical treatments occurring
simultaneously for all treatment groups. For mRNA experiments using total tissue, it would be
interesting to use multiplex tags for sequencing RNA from individual animals because this
would enable us to look for correlations between gene expression changes and differences in
cocaine responsiveness between individual mice.
Additionally, as mentioned in the introduction, all drugs of abuse ultimately cause
enhanced signaling in the nucleus accumbens (NAc)83. Studies using different drugs of abuse
and different drug treatment paradigms would therefore be interesting to compare to the
data presented here. Profiling the molecular differences in the brain between experimenteradministered and self-administered cocaine could potentially provide insight into the genes
underlying motivation and drug-seeking behavior. Studies to profile gene expression after
alternate drugs of abuse, such as morphine, amphetamine, and methamphetamine, would

121

122

help establish the overlapping signaling pathways common to all drugs as well as those
unique to a particular drug.
The mesolimbic dopamine system is comprised of a variety of cell types. The
sequencing data presented here therefore derive from a heterogeneous population of cells. A
number of recent experiments suggest that gene expression differs significantly from one cell
to the next 31,366-369. A recently developed technique allows one to isolate cell-type specific
translating RNA using eGFP-tagged ribosomes: the translating ribosome affinity purification
(TRAP) method 370. In this method, generation of transgenic mice expressing an
eGFP/ribosomal fusion protein controlled by a cell-type specific driver enables specific
extraction of labeled polysomes using antibodies to eGFP. The characterization of cell-type
specific mRNA expression could potentially illuminate important molecules and signaling
pathways involved in drug abuse that were obscured by the heterogeneity of mixed tissue
lysates.
It would also be interesting to investigate epigenetic modifications to DNA and
histones as a result of drug exposure using RNA-Seq technology. Epigenetic changes are
known to occur in many neuropsychiatric disorders371-373, and recent evidence points to a role
for epigenetics in the response of the brain to drugs of abuse374-378.

Analytical approaches
The methodology underlying high-throughput sequencing is undergoing constant
improvement, which makes comparisons between recent data sets and older data sets,
obtained with what was then "state of the art", very difficult. Even using one method and a
highly expressed gene such as Actb (β-actin), sequence coverage across different exons is far
from uniform (Fig. 1.2); these differences are even more pronounced when comparisons are
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made between data sets generated with 37 bp reads and 100 bp reads. Difficulties of this type
will presumably be minimized as the technology matures.
For both editing and alternative splicing, a major impediment to data interpretation is
the general lack of knowledge regarding the functional significance of these events. Does a
given event occur in a functionally important region of the gene and alter its function? Until
more is known about individual events, genome-wide studies of all detected instances of
editing or alternative splicing in various treatment paradigms does little more than generate
data.

RNA Editing
Adenosine to inosine (A-to-I) RNA editing is a post-transcriptional modification
catalyzed by a family of widely expressed double-stranded RNA-specific adenosine
deaminases acting on RNA (ADARs)9,379-381. In mammals, RNA editing alters the protein
sequence (recoding) at a small proportion of all identified editing sites because the majority of
A-to-I events reside in intronic, untranslated, or intergenic regions382-386. Comprehensive
analysis of mRNA editing in our existing datasets was complicated by the uneven coverage of
aligning reads and the number of genes in which more than one editing event occurs over a
short distance. Realignment of sequence reads to allow more than two A/G mismatches could
potentially enhance the existing analyses, however deeper sequencing and PCR validation will
be required for more complete analysis.
Editing events within the coding regions of a number of neurotransmitter receptors
known to respond to cocaine cause changes to their RNA processing, channel subunit
maturation/assembly, kinetics, gating properties, and trafficking, altering synaptic
transmission387. We identified 15 A-to-I potential editing events occurring in five sequence
libraries (NAc Saline, Cocaine, Withdrawal and PSD Saline and Cocaine) and 14 additional
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events occurring in four of the five libraries (Table 6.1). Editing would lead to a change in
protein coding in 12 of the 29 identified sites. The remaining identified sites fell in introns, 5’ or
3’ UTRs, or were from noncoding RNAs.
We detected many of the functionally significant editing events known to occur in the
coding regions of the glutamate, serotonin, GABA, and kainate neurotransmitter receptors
(Fig. 6.1). Three editing sites were identified in the ionotropic glutamate receptor, Gria2
(alpha-amino-3-hydroxy-5-methyl-4-isoxazol glutamate receptor, AMPA; also known as GluR2).
Editing of the Q/R site alters channel calcium permeability and nearly complete Q/R editing is
required for viability379,389. While the Q/R site was nearly 100% edited in all samples, partial
editing occurred at the R/G site (Fig. 6.1A); receptors edited at the R/G site exhibit faster
recovery from desensitization379. Under baseline conditions, PSD-localized Gria2 transcripts
show less R/G editing than total tissue Gria2 transcripts. Gria2 R/G editing frequency at the
PSD increased following cocaine exposure, while total tissue Gria2 R/G editing was unaltered
(Fig. 6.1A).
Editing was detected at four sites in the serotonin receptor 5-HT2C (Htr2c), one site in
Gabra3 (gamma-aminobutyric acid type A3 receptor), and at several sites in the kainate
receptors Grik1 and Grik2 (Fig. 6.1B,C and Table 6.1). The serotonin receptor, 5-HT2C (Htr2c), is
an extreme example of a gene in which more than one editing event occurs over a short
distance; it has 5 A-to-I editing events in the span of 13 nucleotides, and it is known that
multiple editing events often occur in a single transcript379,388. Similarly, we observed a K/E
recoding editing event of unknown functional significance in Cyfip2 (cytoplasmic FMR1
interacting protein 2), with lower baseline PSD editing that increased after cocaine (Fig. 6.1D).
The editing profile for E/G recoding in a region of the calcium-dependent secretion activator 1
(CADPS) protein crucial for its interaction with secretory vesicles391 was below 40% in all tissue
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100.0 ± 0.0

Myo3a

chr2:22445901

Intron

802 (47)

100.0 ± 0.0

561 (27)

100.0 ± 0.0

357 (17)

100.0 ± 0.0

31 (3)

90.3 ± 5.3

17 (0)

35.3 ± 11.6

Rpa1

chr11:75114517

16 (12)

81.3 ± 9.8

11 (7)

72.7 ± 13.4

5 (3)

80.0 ± 17.9

135 (111)

97.8 ± 1.3

105 (88)

88.6 ± 3.1

7 (5)

57.1 ± 18.7

8 (6)

37.5 ± 17.1

4 (4)

75.0 ± 21.7

91 (85)

68.1 ± 4.9

121 (120)

100.0 ± 0.0

65 (37)

64.6 ± 5.9

65 (38)

67.7 ± 5.8

31 (22)

61.3 ± 8.7

0 (0)

Taf1b

chr12:25194319

Tmem63b

chr17:45799898

3’-UTR
N/D or
E/G
Q/R

Zfp352

chr4:89892206

3’-UTR

18 (1)

100.0 ± 0.0

8 (0)

100.0 ± 0.0

7 (1)

100.0 ± 0.0

112 (2)

Zfp804b

chr5:7276845

Intron

1145 (103)

99.8 ± 0.1

573 (47)

99.7 ± 0.2

439 (39)

100.0 ± 0.0

121 (6)

61 (59)

62.3 ± 6.2

100.0 ± 0.0

118 (6)

100.0 ± 0.0

100.0 ± 0.0

190 (6)

100.0 ± 0.0

Table 6.1 Table of A-to-I RNA editing events
Identified potential RNA editing events in RNA-Seq libraries from NAc tissue lysates (Saline, Cocaine, Withdrawal) and striatal PSDs (Saline, Cocaine) . Table
details the gene symbol, genomic coordinate, editing site information including recoding event, raw read depth with PHRED-score quality adjusted
coverage for reads ≥ 30, and the percent alternate base ± 95% confidence interval (CI). Site D of Htr2c was detailed by Burns et al. (1997)388.
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Figure 6.1 A-to-I RNA editing in select genes
Mismatch identification and quality filtering was performed using SAMTools pileup and varFilter390.
Potential A-to-I editing sites occurring in multiple sequencing libraries were identified. Frequency of Ato-I edits at the indicated genomic coordinate is shown as percent editing for (A) Gria2, (B) Htr2c, (C)
Gabra3, (D) Cyfip2, (E) Cadps, and (F) Gria3. Recoding is indicated by the single letter amino acid code
before the genomic coordinate. Sites A, B, and D of Htr2c were previously described388. Abbreviations: S,
Saline; C, Cocaine; W, Withdrawal.
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samples and at the PSDs of saline-treated mice but increased to 80% at the PSD after cocaine
(Fig. 6.1E).
Editing of the ionotropic glutamate receptor, Gria3 (also known as GluR3) occurs in the
ligand interaction domain and causes R/G recoding392. Editing at this site is low in embryonic
rat brain and increases markedly as development progresses; 80-90% of Gria3 transcripts are
edited in humans393. Editing at the R/G site enables rapid recovery from desensitization
thereby permitting a sustained response to rapid stimuli. It is believed that editing at this site
occurs prior to splicing and can alter splice efficiency387. Consistent with previously published
reports, we observed a very high degree of editing (< 80%) at the R/G site in all samples
irrespective of treatment paradigm (Fig. 6.1F).
Of note, amongst the genes with editing sites whose usage was responsive to cocaine
(4930578G10Rik, Cadps, Cyfip2, Gpr137b, Gria2, Taf1b), editing at the PSD and in tissue lysates
changed in opposite directions or only differed in the PSD (Table 6.1).

Alternative Splicing
Similarly, our analysis of alternative splicing of the described mRNAs was incomplete
and merits revisiting. While options exist for alternate isoform analysis25,26,394, the annotation of
the mouse genome is far from complete, meaning that the available gene annotations
undergo frequent changes. As with editing, the databases of known alternative splicing
events are quite imperfect, which can produce misleading analyses.
Between 92 and 97% of multi-exon human genes are alternatively spliced7,395,396 and
splicing levels are especially high in the brain, where it plays an important role in synaptic
plasticity33,397 ,398-402. For example, inclusion or exclusion of the three alternatively spliced exons
of the NR1 subunit of the NMDA receptor is activity-dependent and affects receptor assembly
and exit from the endoplasmic reticulum, trafficking, phosphorylation, and pharmacological
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properties400. Although approximately 10% of aligning reads from the NAc lysates and 20%
from striatal PSD libraries map to annotated exon-exon junctions, deeper coverage is needed
to evaluate splicing of transcripts like those encoding NR1.
Since Methyl CpG Binding Protein 2 (Mecp2) mRNA is known to affect behavioral
responses to cocaine and is alternatively spliced125,374,377,403, we carried out a direct analysis of
PSD junction reads mapping to it (Fig. 6.2). Inclusion of exons 1, 2 and 3 allows translation to
start in exon 2, generating MECP2A; when exon 2 is excluded, translation starts in exon 1,
generating MECP2B404,405. Preliminary analysis shows that in the Sal PSD library, more reads
spanned the junction between exons 1 and 2 or 2 and 3 (26 reads support inclusion of exon 2)
than the junction between exons 1 and 3 (3 reads support exclusion of exon 2). In contrast, in
the Coc PSD library, no junction reads supported exon 2 inclusion (MECP2A) while 4 junction
reads supported exon 2 exclusion (MECP2B) (Fig. 6.2). Our data suggest a switch from MECP2A
to the more readily translated MECP2B transcript at the PSD following cocaine treatment.
MECP2, a transcriptional regulator, was known to localize to the PSD66,406 and transcript
levels were high enough to allow a preliminary analysis of its splicing. The longer N-terminus
of MECP2B is compositionally similar to extracellular signal-regulated kinase-1 and is
hypothesized to play a role in coupling synaptic signaling to regulation of transcription404.
Exclusion of exon 2 from PSD-localized transcripts following cocaine treatment may facilitate
synapse-to-nucleus signaling by shifting expression towards MECP2B. Recent studies
implicate MECP2 and other epigenetic modifications in the molecular response to chronic
cocaine125,374,377,403. These preliminary observations should be followed up with further studies.
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Figure 6.2 Alternative splicing of Mecp2
The exon/intron structure of the Mecp2 gene is shown; exclusion of exon 2 generates MECP2B
(NM_001081979, variant 1) while inclusion of exon 2 generates MECP2A (NM_010788, variant 2). Reads
observed in the striatal PSD Sal and Coc libraries are shown.
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Conceptual and integrative approaches
Knockout and transgenic mouse models have provided invaluable insights for
investigations into the behavioral, biochemical, and molecular effects mediated by single
genes. The changes that occur as a result of drug abuse are widespread and occur at multiple
levels of gene expression: epigenetic, transcriptional, post-transcriptional, translational, and
post-translational. These changes most likely involve multiple brain regions and cell-types and
act in a system-wide manner. At the present time we lack the data and analytic tools necessary
to integrate all of these drug-induced changes into a single cohesive model. Global studies
such as those outlined in the previous chapters emphasize the broad effects of drug exposure
on neuronal gene expression. They emphasize the need for an integrative approach that
combines mRNA, miRNA, and protein expression profiling with focused studies and innovative
behavioral paradigms in pursuit of the factors that underlie addiction and develop integrated
therapeutic approaches.
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